Gene Symbol | Gene ID | Gene Info |
---|---|---|
E2f1
|
ENSMUSG00000027490.11 | E2F transcription factor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_154569188_154570416 | E2f1 | 82 | 0.945459 | 0.79 | 5.9e-13 | Click! |
chr2_154568994_154569145 | E2f1 | 651 | 0.553540 | 0.73 | 3.9e-10 | Click! |
chr2_154577420_154577745 | E2f1 | 7690 | 0.105489 | -0.61 | 9.7e-07 | Click! |
chr2_154568534_154568688 | E2f1 | 1109 | 0.339499 | 0.51 | 5.9e-05 | Click! |
chr2_154568786_154568937 | E2f1 | 859 | 0.436317 | 0.42 | 1.3e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr13_23760830_23761749 | 20.74 |
H4c1 |
H4 clustered histone 1 |
59 |
0.86 |
chr15_79690079_79691459 | 20.44 |
Gtpbp1 |
GTP binding protein 1 |
76 |
0.92 |
chr15_102470670_102471447 | 16.77 |
Pcbp2 |
poly(rC) binding protein 2 |
10 |
0.95 |
chr2_38286754_38287566 | 16.68 |
Dennd1a |
DENN/MADD domain containing 1A |
28 |
0.97 |
chr15_98933816_98934775 | 16.22 |
Gm41396 |
predicted gene, 41396 |
30 |
0.62 |
chr17_34586512_34587397 | 16.11 |
Notch4 |
notch 4 |
9 |
0.91 |
chr3_14886091_14887033 | 15.53 |
Car2 |
carbonic anhydrase 2 |
77 |
0.97 |
chr11_102316544_102317735 | 15.04 |
Ubtf |
upstream binding transcription factor, RNA polymerase I |
148 |
0.92 |
chr5_23850355_23851323 | 14.60 |
2700038G22Rik |
RIKEN cDNA 2700038G22 gene |
238 |
0.81 |
chr11_78065958_78066240 | 14.36 |
Mir144 |
microRNA 144 |
6906 |
0.08 |
chr8_11008854_11009914 | 13.97 |
Irs2 |
insulin receptor substrate 2 |
926 |
0.42 |
chr18_36274707_36275097 | 13.67 |
Pura |
purine rich element binding protein A |
6195 |
0.2 |
chr12_8770800_8772245 | 13.33 |
Sdc1 |
syndecan 1 |
109 |
0.78 |
chr2_148045489_148046522 | 13.14 |
Foxa2 |
forkhead box A2 |
57 |
0.97 |
chr14_70074487_70075571 | 13.07 |
Egr3 |
early growth response 3 |
2174 |
0.25 |
chr4_129513695_129514851 | 12.80 |
Marcksl1 |
MARCKS-like 1 |
692 |
0.46 |
chr7_16313509_16314466 | 12.75 |
Bbc3 |
BCL2 binding component 3 |
470 |
0.71 |
chr5_143731658_143732384 | 12.70 |
Usp42 |
ubiquitin specific peptidase 42 |
259 |
0.91 |
chr10_128525093_128526268 | 12.53 |
Esyt1 |
extended synaptotagmin-like protein 1 |
188 |
0.63 |
chrX_142680720_142682167 | 12.45 |
Tmem164 |
transmembrane protein 164 |
25 |
0.98 |
chr8_70698268_70700333 | 12.28 |
Jund |
jun D proto-oncogene |
351 |
0.45 |
chr10_127508848_127510720 | 12.28 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr4_135855773_135856058 | 12.24 |
Srsf10 |
serine and arginine-rich splicing factor 10 |
37 |
0.95 |
chr6_144370811_144371030 | 11.90 |
Sox5os2 |
SRY (sex determining region Y)-box 5, opposite strand 2 |
110305 |
0.07 |
chr1_106171607_106172350 | 11.70 |
Phlpp1 |
PH domain and leucine rich repeat protein phosphatase 1 |
226 |
0.72 |
chr4_140701770_140702866 | 11.61 |
Rcc2 |
regulator of chromosome condensation 2 |
845 |
0.47 |
chr6_115852875_115853903 | 11.36 |
Mbd4 |
methyl-CpG binding domain protein 4 |
18 |
0.55 |
chr5_106964155_106965054 | 11.24 |
Cdc7 |
cell division cycle 7 (S. cerevisiae) |
43 |
0.98 |
chr13_63564531_63566515 | 11.16 |
Ptch1 |
patched 1 |
212 |
0.91 |
chr8_70609185_70610414 | 11.11 |
Gm45546 |
predicted gene 45546 |
626 |
0.42 |
chr4_125085396_125085925 | 10.88 |
Meaf6 |
MYST/Esa1-associated factor 6 |
399 |
0.61 |
chr11_87126714_87127907 | 10.41 |
Trim37 |
tripartite motif-containing 37 |
5 |
0.84 |
chr5_137684632_137685345 | 10.28 |
Agfg2 |
ArfGAP with FG repeats 2 |
262 |
0.81 |
chr11_105029086_105029270 | 10.26 |
Gm11622 |
predicted gene 11622 |
1979 |
0.28 |
chr18_77870043_77870321 | 10.25 |
Epg5 |
ectopic P-granules autophagy protein 5 homolog (C. elegans) |
68283 |
0.09 |
chr2_121955584_121956519 | 10.09 |
Mageb3 |
melanoma antigen, family B, 3 |
41 |
0.5 |
chr19_47178446_47179494 | 9.98 |
Neurl1a |
neuralized E3 ubiquitin protein ligase 1A |
52 |
0.95 |
chr9_111057150_111057866 | 9.89 |
Ccrl2 |
chemokine (C-C motif) receptor-like 2 |
11 |
0.95 |
chr14_79300760_79302137 | 9.73 |
Rgcc |
regulator of cell cycle |
197 |
0.94 |
chr5_147299227_147299912 | 9.71 |
Cdx2 |
caudal type homeobox 2 |
7701 |
0.1 |
chr5_96162084_96163134 | 9.68 |
Cnot6l |
CCR4-NOT transcription complex, subunit 6-like |
619 |
0.75 |
chr10_80150235_80151164 | 9.68 |
Midn |
midnolin |
242 |
0.82 |
chr8_33731690_33732464 | 9.66 |
Gtf2e2 |
general transcription factor II E, polypeptide 2 (beta subunit) |
35 |
0.77 |
chr2_153492229_153493481 | 9.52 |
4930404H24Rik |
RIKEN cDNA 4930404H24 gene |
65 |
0.82 |
chr1_46852832_46854284 | 9.36 |
Slc39a10 |
solute carrier family 39 (zinc transporter), member 10 |
488 |
0.78 |
chrX_71556134_71556919 | 9.35 |
Hmgb3 |
high mobility group box 3 |
420 |
0.84 |
chr7_4739300_4740219 | 9.25 |
Kmt5c |
lysine methyltransferase 5C |
356 |
0.63 |
chr12_76709620_76710348 | 9.16 |
Sptb |
spectrin beta, erythrocytic |
39 |
0.98 |
chrX_42067696_42069057 | 9.12 |
Xiap |
X-linked inhibitor of apoptosis |
22 |
0.98 |
chr19_41482494_41483686 | 9.06 |
Lcor |
ligand dependent nuclear receptor corepressor |
61 |
0.98 |
chr5_109557850_109558797 | 9.01 |
Crlf2 |
cytokine receptor-like factor 2 |
613 |
0.67 |
chr2_127362969_127363285 | 9.01 |
Adra2b |
adrenergic receptor, alpha 2b |
81 |
0.96 |
chr12_11265672_11266639 | 8.96 |
Smc6 |
structural maintenance of chromosomes 6 |
14 |
0.85 |
chr2_28616890_28617255 | 8.96 |
Gfi1b |
growth factor independent 1B |
1667 |
0.23 |
chr19_7557319_7557505 | 8.88 |
Plaat3 |
phospholipase A and acyltransferase 3 |
47 |
0.97 |
chr3_137968367_137968564 | 8.86 |
Dapp1 |
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
12598 |
0.12 |
chr14_31019341_31019698 | 8.82 |
Pbrm1 |
polybromo 1 |
311 |
0.48 |
chr13_23533504_23534327 | 8.78 |
H2ac10 |
H2A clustered histone 10 |
9 |
0.78 |
chr3_103171228_103172264 | 8.77 |
Bcas2 |
breast carcinoma amplified sequence 2 |
3 |
0.97 |
chr17_53566897_53568169 | 8.75 |
Kat2b |
K(lysine) acetyltransferase 2B |
562 |
0.71 |
chr2_78868968_78869664 | 8.69 |
Ube2e3 |
ubiquitin-conjugating enzyme E2E 3 |
18 |
0.98 |
chr2_28582646_28583374 | 8.64 |
Gtf3c5 |
general transcription factor IIIC, polypeptide 5 |
22 |
0.95 |
chr7_25686729_25687529 | 8.61 |
Tgfb1 |
transforming growth factor, beta 1 |
127 |
0.91 |
chr10_110919563_110920722 | 8.53 |
Csrp2 |
cysteine and glycine-rich protein 2 |
48 |
0.97 |
chr6_120603986_120604161 | 8.52 |
Gm44124 |
predicted gene, 44124 |
23897 |
0.13 |
chr8_122550655_122551216 | 8.50 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
394 |
0.72 |
chr2_129226918_129227069 | 8.50 |
9830144P21Rik |
RIKEN cDNA 9830144P21 gene |
555 |
0.51 |
chr1_86527639_86529135 | 8.44 |
Ptma |
prothymosin alpha |
1580 |
0.31 |
chr11_19924323_19926342 | 8.43 |
Spred2 |
sprouty-related EVH1 domain containing 2 |
890 |
0.71 |
chr4_133967146_133967733 | 8.43 |
Hmgn2 |
high mobility group nucleosomal binding domain 2 |
2 |
0.97 |
chr13_21750426_21750639 | 8.41 |
H4c12 |
H4 clustered histone 12 |
27 |
0.89 |
chr14_20793233_20794132 | 8.38 |
Camk2g |
calcium/calmodulin-dependent protein kinase II gamma |
284 |
0.68 |
chr9_100643446_100643943 | 8.38 |
Stag1 |
stromal antigen 1 |
58 |
0.97 |
chr2_125122926_125123420 | 8.37 |
Myef2 |
myelin basic protein expression factor 2, repressor |
241 |
0.89 |
chr17_84188466_84188948 | 8.36 |
Zfp36l2 |
zinc finger protein 36, C3H type-like 2 |
760 |
0.58 |
chr18_4921251_4922052 | 8.25 |
Svil |
supervillin |
75 |
0.98 |
chr8_23034947_23035228 | 8.24 |
Ank1 |
ankyrin 1, erythroid |
12 |
0.98 |
chr4_119190676_119190850 | 8.19 |
Ermap |
erythroblast membrane-associated protein |
752 |
0.43 |
chr13_58402391_58403113 | 8.18 |
Rmi1 |
RecQ mediated genome instability 1 |
52 |
0.56 |
chr16_4559726_4560765 | 8.10 |
Tfap4 |
transcription factor AP4 |
391 |
0.8 |
chr7_102441603_102442532 | 8.08 |
Rrm1 |
ribonucleotide reductase M1 |
24 |
0.95 |
chr7_101107926_101108650 | 8.05 |
Fchsd2 |
FCH and double SH3 domains 2 |
445 |
0.81 |
chr7_100492773_100493523 | 7.92 |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
189 |
0.88 |
chr5_151368381_151369217 | 7.91 |
1700028E10Rik |
RIKEN cDNA 1700028E10 gene |
81 |
0.83 |
chr1_180813955_180814487 | 7.90 |
H3f3a |
H3.3 histone A |
278 |
0.6 |
chr13_98925848_98926492 | 7.80 |
Tnpo1 |
transportin 1 |
184 |
0.92 |
chr4_44004263_44004437 | 7.80 |
Clta |
clathrin, light polypeptide (Lca) |
102 |
0.96 |
chr3_103967821_103968701 | 7.77 |
Phtf1 |
putative homeodomain transcription factor 1 |
3 |
0.82 |
chr3_40800170_40800914 | 7.73 |
Plk4 |
polo like kinase 4 |
239 |
0.89 |
chr17_47909349_47909983 | 7.72 |
Gm15556 |
predicted gene 15556 |
12712 |
0.13 |
chr13_55329820_55330659 | 7.71 |
Mxd3 |
Max dimerization protein 3 |
416 |
0.72 |
chr4_129377050_129377794 | 7.58 |
Zbtb8a |
zinc finger and BTB domain containing 8a |
694 |
0.53 |
chr11_109550376_109550622 | 7.57 |
Arsg |
arylsulfatase G |
6745 |
0.17 |
chr7_100500401_100501097 | 7.55 |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
2403 |
0.14 |
chr4_141060020_141060759 | 7.53 |
Crocc |
ciliary rootlet coiled-coil, rootletin |
156 |
0.92 |
chr11_69718782_69718958 | 7.52 |
Gm12307 |
predicted gene 12307 |
11714 |
0.05 |
chr8_107095919_107096832 | 7.50 |
Terf2 |
telomeric repeat binding factor 2 |
139 |
0.66 |
chr17_70850487_70852089 | 7.49 |
Tgif1 |
TGFB-induced factor homeobox 1 |
81 |
0.94 |
chr2_60880792_60881813 | 7.43 |
Rbms1 |
RNA binding motif, single stranded interacting protein 1 |
136 |
0.98 |
chr11_119299981_119300542 | 7.30 |
Eif4a3 |
eukaryotic translation initiation factor 4A3 |
172 |
0.92 |
chr1_74661633_74662275 | 7.28 |
Ttll4 |
tubulin tyrosine ligase-like family, member 4 |
137 |
0.94 |
chr6_47595278_47595639 | 7.27 |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
117 |
0.96 |
chr6_38911263_38911582 | 7.23 |
Tbxas1 |
thromboxane A synthase 1, platelet |
7558 |
0.21 |
chr14_115040506_115042372 | 7.23 |
Mir17hg |
Mir17 host gene (non-protein coding) |
1440 |
0.19 |
chr7_48880950_48881793 | 7.22 |
Gm2788 |
predicted gene 2788 |
71 |
0.71 |
chr5_108694436_108695224 | 7.18 |
Fgfrl1 |
fibroblast growth factor receptor-like 1 |
328 |
0.81 |
chr19_43752643_43753526 | 7.18 |
Cutc |
cutC copper transporter |
14 |
0.56 |
chr11_79054816_79055084 | 7.14 |
Ksr1 |
kinase suppressor of ras 1 |
2677 |
0.28 |
chr1_75136418_75136604 | 7.12 |
Cnppd1 |
cyclin Pas1/PHO80 domain containing 1 |
1295 |
0.23 |
chr3_144720129_144720738 | 7.09 |
Sh3glb1 |
SH3-domain GRB2-like B1 (endophilin) |
98 |
0.95 |
chr9_66158067_66158548 | 7.09 |
Dapk2 |
death-associated protein kinase 2 |
72 |
0.97 |
chr5_135107788_135108074 | 7.08 |
Mlxipl |
MLX interacting protein-like |
1013 |
0.35 |
chr2_122348439_122348831 | 7.08 |
Shf |
Src homology 2 domain containing F |
5496 |
0.14 |
chr15_98837479_98837647 | 7.07 |
Kmt2d |
lysine (K)-specific methyltransferase 2D |
399 |
0.68 |
chr9_65890051_65890358 | 6.96 |
Pclaf |
PCNA clamp associated factor |
33 |
0.96 |
chr17_25944896_25945091 | 6.96 |
Nhlrc4 |
NHL repeat containing 4 |
32 |
0.5 |
chr2_52072899_52073404 | 6.94 |
Rif1 |
replication timing regulatory factor 1 |
79 |
0.98 |
chr11_108424530_108425250 | 6.94 |
Cep112 |
centrosomal protein 112 |
302 |
0.86 |
chr14_77036606_77036817 | 6.91 |
Ccdc122 |
coiled-coil domain containing 122 |
61 |
0.51 |
chr17_39844649_39844816 | 6.90 |
CT010467.1 |
18s RNA, related sequence 5 |
1621 |
0.35 |
chr7_97453380_97453921 | 6.90 |
Kctd14 |
potassium channel tetramerisation domain containing 14 |
428 |
0.78 |
chr14_70624737_70624974 | 6.90 |
Dmtn |
dematin actin binding protein |
1300 |
0.31 |
chrX_94366585_94367598 | 6.90 |
Apoo |
apolipoprotein O |
26 |
0.81 |
chr11_21994299_21994805 | 6.89 |
Otx1 |
orthodenticle homeobox 1 |
7063 |
0.25 |
chr12_8674358_8674928 | 6.86 |
Pum2 |
pumilio RNA-binding family member 2 |
38 |
0.98 |
chr5_112324889_112325204 | 6.84 |
Tfip11 |
tuftelin interacting protein 11 |
1312 |
0.28 |
chrX_48452801_48453015 | 6.83 |
Elf4 |
E74-like factor 4 (ets domain transcription factor) |
1261 |
0.46 |
chr13_47105669_47106033 | 6.82 |
Dek |
DEK oncogene (DNA binding) |
21 |
0.91 |
chr11_107092787_107092963 | 6.78 |
Bptf |
bromodomain PHD finger transcription factor |
25670 |
0.14 |
chr4_129188973_129189769 | 6.77 |
S100pbp |
S100P binding protein |
127 |
0.78 |
chr9_123478214_123478586 | 6.76 |
Limd1 |
LIM domains containing 1 |
306 |
0.89 |
chr17_39844374_39844569 | 6.75 |
CT010467.1 |
18s RNA, related sequence 5 |
1882 |
0.31 |
chr13_21721409_21722546 | 6.74 |
H2bc14 |
H2B clustered histone 14 |
67 |
0.58 |
chr13_23581338_23582324 | 6.74 |
H4c4 |
H4 clustered histone 4 |
233 |
0.73 |
chr6_134928567_134929409 | 6.74 |
Lockd |
lncRNA downstream of Cdkn1b |
104 |
0.92 |
chr2_153161013_153161878 | 6.71 |
Tm9sf4 |
transmembrane 9 superfamily protein member 4 |
96 |
0.96 |
chr9_103364932_103365323 | 6.71 |
Cdv3 |
carnitine deficiency-associated gene expressed in ventricle 3 |
0 |
0.97 |
chr19_6291067_6291820 | 6.70 |
Ehd1 |
EH-domain containing 1 |
2738 |
0.11 |
chr10_61413342_61413765 | 6.68 |
Nodal |
nodal |
4419 |
0.13 |
chr7_114275561_114276736 | 6.68 |
Psma1 |
proteasome subunit alpha 1 |
30 |
0.98 |
chr11_60104775_60106860 | 6.67 |
Rai1 |
retinoic acid induced 1 |
640 |
0.67 |
chr4_132048326_132049017 | 6.66 |
Epb41 |
erythrocyte membrane protein band 4.1 |
407 |
0.5 |
chr9_35116070_35117303 | 6.62 |
4930581F22Rik |
RIKEN cDNA 4930581F22 gene |
42 |
0.69 |
chr1_75179592_75180552 | 6.62 |
Abcb6 |
ATP-binding cassette, sub-family B (MDR/TAP), member 6 |
214 |
0.81 |
chr4_46407004_46407329 | 6.61 |
Hemgn |
hemogen |
2930 |
0.18 |
chr2_167447771_167447937 | 6.60 |
Slc9a8 |
solute carrier family 9 (sodium/hydrogen exchanger), member 8 |
3112 |
0.22 |
chr16_30063252_30064537 | 6.58 |
Hes1 |
hes family bHLH transcription factor 1 |
490 |
0.76 |
chr14_47241050_47241230 | 6.56 |
Wdhd1 |
WD repeat and HMG-box DNA binding protein 1 |
4130 |
0.11 |
chr16_94569391_94569773 | 6.55 |
Dyrk1a |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1a |
428 |
0.84 |
chr13_21734972_21735174 | 6.55 |
H4c11 |
H4 clustered histone 11 |
9 |
0.9 |
chr3_103130480_103130728 | 6.55 |
Dennd2c |
DENN/MADD domain containing 2C |
3048 |
0.17 |
chr1_86525613_86527056 | 6.53 |
Ptma |
prothymosin alpha |
392 |
0.81 |
chr12_105009687_105009910 | 6.53 |
Syne3 |
spectrin repeat containing, nuclear envelope family member 3 |
11 |
0.96 |
chr4_136177837_136178388 | 6.51 |
E2f2 |
E2F transcription factor 2 |
2671 |
0.2 |
chr4_33923766_33925291 | 6.51 |
Cnr1 |
cannabinoid receptor 1 (brain) |
65 |
0.98 |
chr14_79451589_79452546 | 6.51 |
Kbtbd6 |
kelch repeat and BTB (POZ) domain containing 6 |
232 |
0.9 |
chr6_124919273_124920636 | 6.49 |
Ptms |
parathymosin |
149 |
0.88 |
chr2_48949106_48950119 | 6.43 |
Mbd5 |
methyl-CpG binding domain protein 5 |
89 |
0.8 |
chr10_81524029_81524513 | 6.43 |
Gna15 |
guanine nucleotide binding protein, alpha 15 |
46 |
0.91 |
chr9_57262451_57262798 | 6.41 |
1700017B05Rik |
RIKEN cDNA 1700017B05 gene |
12 |
0.97 |
chr11_74896307_74898160 | 6.41 |
Sgsm2 |
small G protein signaling modulator 2 |
173 |
0.84 |
chr11_117825409_117825666 | 6.41 |
Tk1 |
thymidine kinase 1 |
280 |
0.54 |
chr13_107021716_107022246 | 6.40 |
Kif2a |
kinesin family member 2A |
46 |
0.9 |
chr9_70678675_70679795 | 6.40 |
Adam10 |
a disintegrin and metallopeptidase domain 10 |
219 |
0.93 |
chr2_132252313_132253101 | 6.39 |
Pcna |
proliferating cell nuclear antigen |
105 |
0.89 |
chr11_4031163_4031533 | 6.32 |
Sec14l4 |
SEC14-like lipid binding 4 |
114 |
0.94 |
chr10_80571146_80571871 | 6.32 |
Klf16 |
Kruppel-like factor 16 |
5813 |
0.08 |
chr1_167802317_167803268 | 6.30 |
Lmx1a |
LIM homeobox transcription factor 1 alpha |
113235 |
0.07 |
chr9_51008308_51009431 | 6.29 |
Sik2 |
salt inducible kinase 2 |
67 |
0.97 |
chr19_53258446_53258597 | 6.28 |
1700001K23Rik |
RIKEN cDNA 1700001K23 gene |
3301 |
0.2 |
chr11_104549984_104550394 | 6.27 |
Cdc27 |
cell division cycle 27 |
203 |
0.73 |
chr8_123156122_123156399 | 6.27 |
Sult5a1 |
sulfotransferase family 5A, member 1 |
1968 |
0.15 |
chr12_84152620_84152807 | 6.27 |
Elmsan1 |
ELM2 and Myb/SANT-like domain containing 1 |
2519 |
0.15 |
chr3_89458994_89459453 | 6.26 |
Pmvk |
phosphomevalonate kinase |
105 |
0.93 |
chr8_78508384_78509084 | 6.22 |
Rbmxl1 |
RNA binding motif protein, X-linked like-1 |
145 |
0.87 |
chr10_75697353_75697856 | 6.20 |
Cabin1 |
calcineurin binding protein 1 |
2771 |
0.19 |
chr11_101448598_101448766 | 6.18 |
Ifi35 |
interferon-induced protein 35 |
112 |
0.89 |
chr8_94983294_94983708 | 6.17 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
870 |
0.47 |
chr1_74506202_74506776 | 6.17 |
Usp37 |
ubiquitin specific peptidase 37 |
206 |
0.7 |
chr17_56303166_56303753 | 6.16 |
Uhrf1 |
ubiquitin-like, containing PHD and RING finger domains, 1 |
59 |
0.95 |
chr13_54611220_54611709 | 6.16 |
Cltb |
clathrin, light polypeptide (Lcb) |
120 |
0.93 |
chr9_62838488_62838893 | 6.14 |
Cln6 |
ceroid-lipofuscinosis, neuronal 6 |
95 |
0.95 |
chr18_82474598_82476191 | 6.14 |
Mbp |
myelin basic protein |
24 |
0.98 |
chr12_70227533_70227906 | 6.10 |
Pygl |
liver glycogen phosphorylase |
36 |
0.6 |
chr2_75703696_75705127 | 6.10 |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
78 |
0.81 |
chr17_10318513_10318707 | 6.10 |
Qk |
quaking |
751 |
0.71 |
chr5_65698076_65698722 | 6.08 |
Pds5a |
PDS5 cohesin associated factor A |
126 |
0.94 |
chr11_97440036_97440725 | 6.08 |
Arhgap23 |
Rho GTPase activating protein 23 |
4095 |
0.19 |
chr17_3557402_3557579 | 6.07 |
Tfb1m |
transcription factor B1, mitochondrial |
244 |
0.59 |
chr5_65763329_65763831 | 6.05 |
N4bp2 |
NEDD4 binding protein 2 |
59 |
0.71 |
chr15_96709352_96710351 | 6.04 |
Gm38144 |
predicted gene, 38144 |
9678 |
0.18 |
chr3_90265231_90266258 | 6.01 |
Dennd4b |
DENN/MADD domain containing 4B |
559 |
0.53 |
chr7_24370444_24370618 | 5.97 |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
193 |
0.87 |
chr16_4558782_4559702 | 5.96 |
Tfap4 |
transcription factor AP4 |
459 |
0.75 |
chr15_79062401_79062814 | 5.94 |
Ankrd54 |
ankyrin repeat domain 54 |
15 |
0.93 |
chr18_50028238_50028565 | 5.92 |
Tnfaip8 |
tumor necrosis factor, alpha-induced protein 8 |
2617 |
0.3 |
chrY_90768118_90768728 | 5.92 |
Gm21860 |
predicted gene, 21860 |
12956 |
0.16 |
chr9_100644028_100644474 | 5.91 |
Stag1 |
stromal antigen 1 |
481 |
0.76 |
chr16_32246433_32247287 | 5.90 |
Fbxo45 |
F-box protein 45 |
298 |
0.52 |
chr3_144201827_144203140 | 5.88 |
Lmo4 |
LIM domain only 4 |
87 |
0.97 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.7 | 20.2 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
6.2 | 18.7 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
5.1 | 5.1 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
5.1 | 15.2 | GO:0042938 | dipeptide transport(GO:0042938) |
4.9 | 14.8 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
4.8 | 14.4 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
4.7 | 18.9 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
4.3 | 12.8 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
4.2 | 16.7 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
4.0 | 12.0 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
3.9 | 23.6 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
3.7 | 11.0 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
3.6 | 14.2 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
3.5 | 14.1 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
3.4 | 13.7 | GO:0098535 | de novo centriole assembly(GO:0098535) |
3.0 | 8.9 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
3.0 | 8.9 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
2.9 | 8.8 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
2.9 | 11.7 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
2.9 | 11.6 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
2.9 | 11.4 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
2.9 | 8.6 | GO:0097167 | circadian regulation of translation(GO:0097167) |
2.8 | 8.3 | GO:0002432 | granuloma formation(GO:0002432) |
2.7 | 5.5 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
2.7 | 18.9 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
2.7 | 10.8 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
2.7 | 2.7 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
2.6 | 7.9 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
2.6 | 5.1 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
2.5 | 10.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
2.5 | 10.2 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
2.5 | 12.4 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
2.4 | 12.1 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
2.4 | 12.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
2.4 | 7.1 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
2.3 | 7.0 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
2.3 | 14.0 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
2.3 | 9.3 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
2.3 | 6.9 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
2.3 | 9.2 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
2.3 | 11.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
2.3 | 4.5 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
2.3 | 6.8 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
2.2 | 20.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
2.2 | 2.2 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
2.2 | 8.8 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
2.2 | 6.5 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
2.2 | 6.5 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
2.2 | 17.3 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
2.1 | 8.6 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
2.1 | 6.4 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
2.1 | 6.4 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
2.1 | 10.3 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
2.1 | 6.2 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
2.1 | 6.2 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
2.0 | 6.1 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
2.0 | 6.1 | GO:0040031 | snRNA modification(GO:0040031) |
2.0 | 6.1 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
2.0 | 8.1 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
2.0 | 2.0 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
1.9 | 7.8 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
1.9 | 3.9 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.9 | 13.6 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
1.9 | 5.8 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
1.9 | 11.4 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
1.9 | 33.7 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
1.9 | 5.6 | GO:0006203 | dGTP catabolic process(GO:0006203) |
1.9 | 7.4 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
1.8 | 7.3 | GO:0050779 | RNA destabilization(GO:0050779) |
1.8 | 5.4 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
1.8 | 7.2 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
1.8 | 3.5 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
1.8 | 10.6 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
1.7 | 5.1 | GO:0001555 | oocyte growth(GO:0001555) |
1.7 | 6.8 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
1.7 | 11.9 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
1.7 | 5.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
1.7 | 6.7 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
1.7 | 3.4 | GO:0044838 | cell quiescence(GO:0044838) |
1.7 | 5.0 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
1.7 | 6.6 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
1.6 | 6.5 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
1.6 | 4.8 | GO:0008050 | female courtship behavior(GO:0008050) |
1.6 | 4.8 | GO:0070827 | chromatin maintenance(GO:0070827) |
1.6 | 6.3 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
1.6 | 4.7 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
1.6 | 6.3 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
1.6 | 4.7 | GO:0006543 | glutamine catabolic process(GO:0006543) |
1.6 | 4.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.5 | 4.6 | GO:1903288 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
1.5 | 4.6 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
1.5 | 4.6 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
1.5 | 10.6 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
1.5 | 4.6 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
1.5 | 4.5 | GO:0046104 | thymidine metabolic process(GO:0046104) |
1.5 | 6.0 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
1.5 | 13.3 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
1.5 | 11.9 | GO:0018095 | protein polyglutamylation(GO:0018095) |
1.5 | 5.9 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
1.5 | 4.4 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
1.5 | 4.4 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
1.5 | 4.4 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
1.5 | 4.4 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
1.5 | 35.0 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
1.5 | 5.8 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
1.4 | 4.3 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
1.4 | 7.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
1.4 | 12.9 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
1.4 | 4.3 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
1.4 | 5.7 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
1.4 | 16.9 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
1.4 | 5.6 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
1.4 | 5.6 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
1.4 | 11.2 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
1.4 | 11.1 | GO:0006000 | fructose metabolic process(GO:0006000) |
1.4 | 4.1 | GO:0030578 | PML body organization(GO:0030578) |
1.4 | 5.5 | GO:0051013 | microtubule severing(GO:0051013) |
1.4 | 10.8 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
1.3 | 6.7 | GO:0046060 | dATP metabolic process(GO:0046060) |
1.3 | 5.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
1.3 | 13.2 | GO:0019985 | translesion synthesis(GO:0019985) |
1.3 | 2.6 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
1.3 | 4.0 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
1.3 | 3.9 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
1.3 | 3.9 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
1.3 | 5.1 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
1.3 | 9.0 | GO:0001842 | neural fold formation(GO:0001842) |
1.3 | 10.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
1.3 | 6.4 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
1.3 | 3.8 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
1.3 | 1.3 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
1.3 | 6.3 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
1.3 | 7.5 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
1.2 | 11.2 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
1.2 | 14.9 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
1.2 | 4.9 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.2 | 7.4 | GO:0070828 | heterochromatin organization(GO:0070828) |
1.2 | 6.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
1.2 | 3.7 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
1.2 | 4.9 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
1.2 | 4.9 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
1.2 | 4.9 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
1.2 | 2.4 | GO:1902075 | cellular response to salt(GO:1902075) |
1.2 | 4.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.2 | 9.6 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
1.2 | 6.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
1.2 | 4.8 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
1.2 | 3.6 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
1.2 | 2.4 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
1.2 | 4.7 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
1.2 | 7.1 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
1.2 | 7.1 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
1.2 | 4.7 | GO:0007296 | vitellogenesis(GO:0007296) |
1.2 | 3.5 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
1.2 | 5.8 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
1.2 | 6.9 | GO:0051382 | kinetochore assembly(GO:0051382) |
1.1 | 1.1 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
1.1 | 2.3 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
1.1 | 2.3 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
1.1 | 3.4 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
1.1 | 3.4 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
1.1 | 4.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
1.1 | 6.8 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
1.1 | 10.2 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
1.1 | 4.5 | GO:0015705 | iodide transport(GO:0015705) |
1.1 | 14.6 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
1.1 | 1.1 | GO:1903278 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
1.1 | 5.6 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
1.1 | 2.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.1 | 9.9 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
1.1 | 2.2 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
1.1 | 4.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
1.1 | 3.3 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
1.1 | 2.2 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
1.1 | 5.4 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
1.1 | 3.2 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
1.1 | 23.7 | GO:0006376 | mRNA splice site selection(GO:0006376) |
1.1 | 8.6 | GO:0007097 | nuclear migration(GO:0007097) |
1.1 | 8.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.1 | 7.5 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
1.1 | 7.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
1.1 | 6.4 | GO:0016266 | O-glycan processing(GO:0016266) |
1.1 | 1.1 | GO:0060374 | mast cell differentiation(GO:0060374) |
1.1 | 4.2 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
1.1 | 5.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
1.1 | 5.3 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
1.1 | 10.6 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
1.1 | 4.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
1.0 | 3.1 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
1.0 | 10.4 | GO:0045332 | phospholipid translocation(GO:0045332) |
1.0 | 3.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
1.0 | 3.1 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
1.0 | 1.0 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
1.0 | 4.1 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
1.0 | 8.2 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
1.0 | 3.1 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
1.0 | 3.1 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.0 | 3.0 | GO:0036166 | phenotypic switching(GO:0036166) |
1.0 | 2.0 | GO:0003383 | apical constriction(GO:0003383) |
1.0 | 6.0 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
1.0 | 3.0 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
1.0 | 3.0 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
1.0 | 5.9 | GO:0007035 | vacuolar acidification(GO:0007035) |
1.0 | 2.9 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
1.0 | 7.9 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
1.0 | 3.9 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
1.0 | 3.9 | GO:0009414 | response to water deprivation(GO:0009414) |
1.0 | 2.9 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
1.0 | 1.9 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
1.0 | 3.9 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
1.0 | 6.8 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
1.0 | 5.8 | GO:0048539 | bone marrow development(GO:0048539) |
1.0 | 1.9 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
1.0 | 3.9 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
1.0 | 2.9 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
1.0 | 1.9 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
1.0 | 2.9 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.0 | 2.9 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.9 | 5.7 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.9 | 4.7 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.9 | 0.9 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.9 | 5.7 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.9 | 2.8 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.9 | 4.7 | GO:0015871 | choline transport(GO:0015871) |
0.9 | 13.0 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.9 | 2.8 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.9 | 12.8 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.9 | 4.6 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.9 | 2.7 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.9 | 4.6 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.9 | 5.4 | GO:1901563 | response to camptothecin(GO:1901563) |
0.9 | 0.9 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.9 | 19.8 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.9 | 1.8 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.9 | 7.2 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.9 | 2.7 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.9 | 3.6 | GO:0048102 | autophagic cell death(GO:0048102) |
0.9 | 5.4 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.9 | 4.5 | GO:0051026 | chiasma assembly(GO:0051026) |
0.9 | 2.7 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.9 | 2.7 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.9 | 3.6 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.9 | 2.7 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.9 | 2.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.9 | 2.6 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.9 | 2.6 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.9 | 10.5 | GO:0043486 | histone exchange(GO:0043486) |
0.9 | 5.2 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.9 | 3.5 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.9 | 2.6 | GO:0080009 | mRNA methylation(GO:0080009) |
0.9 | 3.5 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.9 | 6.9 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.9 | 5.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.9 | 1.7 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.9 | 6.9 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.9 | 9.5 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.9 | 3.4 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.9 | 1.7 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.9 | 1.7 | GO:1904193 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.9 | 0.9 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.9 | 3.4 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.8 | 0.8 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.8 | 5.9 | GO:0060242 | contact inhibition(GO:0060242) |
0.8 | 39.7 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.8 | 1.7 | GO:0042891 | antibiotic transport(GO:0042891) |
0.8 | 0.8 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.8 | 2.5 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.8 | 1.7 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.8 | 0.8 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.8 | 4.1 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.8 | 0.8 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.8 | 0.8 | GO:0071947 | protein K29-linked deubiquitination(GO:0035523) protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) protein K33-linked deubiquitination(GO:1990168) |
0.8 | 7.3 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.8 | 1.6 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.8 | 1.6 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.8 | 2.4 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.8 | 2.4 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.8 | 2.4 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.8 | 6.4 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.8 | 0.8 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.8 | 4.0 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
0.8 | 4.0 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.8 | 7.1 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.8 | 0.8 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.8 | 1.6 | GO:0033121 | regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.8 | 2.4 | GO:0051168 | nuclear export(GO:0051168) |
0.8 | 1.6 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.8 | 1.6 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.8 | 2.3 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.8 | 0.8 | GO:0042023 | DNA endoreduplication(GO:0042023) |
0.8 | 1.6 | GO:1903521 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.8 | 3.9 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.8 | 2.3 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.8 | 2.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.8 | 0.8 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.8 | 3.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.8 | 0.8 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.8 | 2.3 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.8 | 1.5 | GO:0061010 | gall bladder development(GO:0061010) |
0.8 | 3.0 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.8 | 2.3 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.8 | 1.5 | GO:0032439 | endosome localization(GO:0032439) |
0.8 | 7.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.8 | 7.5 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.7 | 2.2 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.7 | 2.2 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.7 | 1.5 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.7 | 5.2 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.7 | 2.2 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.7 | 2.2 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.7 | 2.9 | GO:0001802 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.7 | 1.5 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.7 | 2.2 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.7 | 6.6 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.7 | 2.9 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.7 | 1.4 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.7 | 6.5 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.7 | 0.7 | GO:1903273 | regulation of sodium ion export(GO:1903273) regulation of sodium ion export from cell(GO:1903276) |
0.7 | 2.2 | GO:0060056 | mammary gland involution(GO:0060056) |
0.7 | 12.2 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.7 | 1.4 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.7 | 2.9 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.7 | 2.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.7 | 2.9 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.7 | 7.8 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.7 | 2.1 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.7 | 9.2 | GO:0042407 | cristae formation(GO:0042407) |
0.7 | 2.1 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.7 | 1.4 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.7 | 7.0 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.7 | 1.4 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.7 | 2.1 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.7 | 1.4 | GO:0051383 | kinetochore organization(GO:0051383) |
0.7 | 4.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.7 | 6.9 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.7 | 2.8 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.7 | 8.9 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.7 | 1.4 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.7 | 2.0 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.7 | 2.0 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.7 | 7.5 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.7 | 4.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.7 | 2.7 | GO:2001252 | positive regulation of chromosome organization(GO:2001252) |
0.7 | 2.0 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.7 | 2.7 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.7 | 4.0 | GO:0044818 | mitotic G2/M transition checkpoint(GO:0044818) |
0.7 | 4.0 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.7 | 2.0 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.7 | 3.3 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.7 | 2.0 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.7 | 2.6 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.7 | 1.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.7 | 3.3 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.7 | 0.7 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
0.7 | 1.3 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.7 | 3.3 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.6 | 1.3 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.6 | 3.9 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.6 | 1.9 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.6 | 1.9 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.6 | 2.6 | GO:0060430 | lung saccule development(GO:0060430) |
0.6 | 2.5 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.6 | 1.9 | GO:0034770 | histone H4-K20 methylation(GO:0034770) histone H4-K20 trimethylation(GO:0034773) |
0.6 | 0.6 | GO:0034204 | lipid translocation(GO:0034204) |
0.6 | 1.3 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.6 | 5.0 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.6 | 1.3 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.6 | 5.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.6 | 0.6 | GO:0061511 | centriole elongation(GO:0061511) |
0.6 | 0.6 | GO:0021590 | cerebellum maturation(GO:0021590) |
0.6 | 2.5 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.6 | 2.4 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.6 | 1.2 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.6 | 3.0 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.6 | 0.6 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.6 | 4.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.6 | 1.2 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.6 | 5.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.6 | 1.8 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.6 | 3.0 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.6 | 1.8 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.6 | 3.5 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.6 | 4.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.6 | 8.8 | GO:0016180 | snRNA processing(GO:0016180) |
0.6 | 1.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.6 | 0.6 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.6 | 2.9 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.6 | 0.6 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.6 | 2.3 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.6 | 1.2 | GO:0044794 | positive regulation by host of viral process(GO:0044794) |
0.6 | 1.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.6 | 1.7 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.6 | 1.1 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.6 | 1.7 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.6 | 2.8 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.6 | 2.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.6 | 14.7 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.6 | 2.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.6 | 3.4 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.6 | 4.5 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.6 | 2.8 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.6 | 4.4 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.6 | 1.7 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.6 | 1.7 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.6 | 3.9 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.6 | 3.3 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.6 | 1.7 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.5 | 1.1 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
0.5 | 1.6 | GO:0007525 | somatic muscle development(GO:0007525) |
0.5 | 1.6 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.5 | 4.9 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.5 | 4.3 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.5 | 1.6 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.5 | 1.6 | GO:0048254 | snoRNA localization(GO:0048254) |
0.5 | 2.7 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.5 | 1.1 | GO:0019042 | viral latency(GO:0019042) |
0.5 | 3.2 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.5 | 1.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.5 | 2.1 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.5 | 1.6 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.5 | 1.6 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.5 | 1.1 | GO:0007619 | courtship behavior(GO:0007619) |
0.5 | 2.1 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.5 | 1.0 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.5 | 1.0 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.5 | 1.0 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.5 | 2.6 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
0.5 | 6.2 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.5 | 1.0 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.5 | 1.5 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.5 | 2.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.5 | 0.5 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.5 | 2.6 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.5 | 4.1 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.5 | 3.1 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.5 | 1.5 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.5 | 1.5 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.5 | 6.6 | GO:0060337 | type I interferon signaling pathway(GO:0060337) |
0.5 | 4.0 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.5 | 4.5 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.5 | 4.5 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.5 | 1.0 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.5 | 1.0 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.5 | 8.0 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.5 | 2.0 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.5 | 8.0 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.5 | 0.5 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.5 | 1.5 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.5 | 1.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.5 | 2.9 | GO:0034063 | stress granule assembly(GO:0034063) |
0.5 | 1.5 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.5 | 1.5 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.5 | 3.4 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.5 | 1.9 | GO:0006116 | NADH oxidation(GO:0006116) |
0.5 | 2.9 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.5 | 2.4 | GO:0014857 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) regulation of skeletal muscle cell proliferation(GO:0014857) |
0.5 | 1.9 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.5 | 2.4 | GO:0042436 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.5 | 2.4 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.5 | 6.2 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.5 | 2.8 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.5 | 1.9 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.5 | 1.4 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.5 | 0.5 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.5 | 0.9 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.5 | 0.9 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.5 | 2.8 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.5 | 0.9 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.5 | 1.4 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.5 | 4.2 | GO:0060539 | diaphragm development(GO:0060539) |
0.5 | 0.5 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.5 | 2.3 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.5 | 7.7 | GO:0070266 | necroptotic process(GO:0070266) |
0.5 | 5.0 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.5 | 0.9 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.5 | 1.8 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.5 | 0.5 | GO:0009264 | deoxyribonucleotide catabolic process(GO:0009264) |
0.5 | 1.4 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.4 | 0.9 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.4 | 1.8 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.4 | 3.6 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.4 | 1.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.4 | 0.9 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.4 | 0.4 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.4 | 1.8 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.4 | 4.8 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.4 | 3.5 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.4 | 0.9 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.4 | 1.3 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.4 | 1.7 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.4 | 1.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.4 | 1.3 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
0.4 | 2.1 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.4 | 0.9 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
0.4 | 3.0 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.4 | 0.4 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.4 | 1.3 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.4 | 0.4 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.4 | 0.8 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.4 | 5.5 | GO:0006903 | vesicle targeting(GO:0006903) |
0.4 | 0.8 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.4 | 1.3 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.4 | 1.7 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.4 | 4.1 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.4 | 4.5 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.4 | 2.0 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.4 | 1.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.4 | 1.2 | GO:0051567 | histone H3-K9 methylation(GO:0051567) |
0.4 | 2.0 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.4 | 1.6 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.4 | 1.2 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.4 | 2.0 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.4 | 0.4 | GO:0045830 | positive regulation of isotype switching(GO:0045830) positive regulation of DNA recombination(GO:0045911) |
0.4 | 7.2 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.4 | 4.8 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.4 | 1.6 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.4 | 0.8 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.4 | 3.6 | GO:0006907 | pinocytosis(GO:0006907) |
0.4 | 3.2 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.4 | 0.8 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.4 | 1.6 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.4 | 0.8 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.4 | 0.8 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.4 | 2.0 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.4 | 22.1 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.4 | 2.0 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) |
0.4 | 4.3 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.4 | 1.9 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.4 | 1.9 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.4 | 0.8 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.4 | 1.2 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.4 | 1.6 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.4 | 3.5 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.4 | 0.4 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.4 | 1.2 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.4 | 1.9 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.4 | 0.8 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.4 | 3.1 | GO:0006301 | postreplication repair(GO:0006301) |
0.4 | 1.9 | GO:0009249 | protein lipoylation(GO:0009249) |
0.4 | 1.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.4 | 0.8 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.4 | 1.5 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.4 | 0.8 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.4 | 3.0 | GO:0070269 | pyroptosis(GO:0070269) |
0.4 | 2.7 | GO:0015825 | L-serine transport(GO:0015825) |
0.4 | 1.9 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.4 | 1.9 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.4 | 1.5 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.4 | 1.5 | GO:0036233 | glycine import(GO:0036233) |
0.4 | 2.6 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.4 | 3.0 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.4 | 3.8 | GO:0009299 | mRNA transcription(GO:0009299) |
0.4 | 9.4 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.4 | 3.0 | GO:0061430 | bone trabecula morphogenesis(GO:0061430) |
0.4 | 1.5 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.4 | 0.7 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.4 | 1.5 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.4 | 3.4 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.4 | 2.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.4 | 1.9 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.4 | 1.5 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.4 | 0.4 | GO:0035973 | aggrephagy(GO:0035973) |
0.4 | 1.1 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.4 | 0.7 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.4 | 1.8 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.4 | 2.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.4 | 4.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.4 | 1.4 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.4 | 1.4 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.4 | 0.4 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.4 | 1.8 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.4 | 2.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.4 | 1.4 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.4 | 1.1 | GO:0097459 | iron ion import into cell(GO:0097459) |
0.4 | 2.5 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.4 | 1.1 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.4 | 2.1 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.4 | 15.7 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.4 | 1.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.4 | 0.7 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.4 | 3.9 | GO:0045116 | protein neddylation(GO:0045116) |
0.4 | 0.7 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.4 | 1.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.4 | 0.4 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.4 | 0.7 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.4 | 0.7 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.4 | 1.4 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.4 | 0.7 | GO:0061042 | vascular wound healing(GO:0061042) |
0.4 | 1.4 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.3 | 0.3 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.3 | 2.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.3 | 2.1 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.3 | 1.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.3 | 0.3 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.3 | 6.2 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.3 | 0.3 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
0.3 | 1.0 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.3 | 1.0 | GO:0006114 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
0.3 | 6.5 | GO:0006284 | base-excision repair(GO:0006284) |
0.3 | 1.0 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.3 | 1.7 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.3 | 2.7 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.3 | 0.3 | GO:0042701 | progesterone secretion(GO:0042701) |
0.3 | 2.7 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.3 | 0.7 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.3 | 2.7 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.3 | 1.4 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.3 | 9.5 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.3 | 4.1 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.3 | 2.4 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.3 | 0.7 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.3 | 0.7 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.3 | 1.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 2.4 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.3 | 1.3 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.3 | 0.7 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.3 | 1.0 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.3 | 0.7 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.3 | 1.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.3 | 5.6 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.3 | 4.6 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.3 | 1.0 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.3 | 1.0 | GO:0000087 | mitotic M phase(GO:0000087) |
0.3 | 3.6 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.3 | 0.7 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.3 | 0.7 | GO:0045738 | negative regulation of DNA repair(GO:0045738) |
0.3 | 1.6 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.3 | 1.6 | GO:0000054 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.3 | 1.0 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.3 | 0.6 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.3 | 1.9 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.3 | 11.5 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.3 | 2.9 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.3 | 1.9 | GO:0072539 | T-helper 17 cell differentiation(GO:0072539) |
0.3 | 1.6 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.3 | 0.9 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) |
0.3 | 1.3 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.3 | 1.3 | GO:0018101 | protein citrullination(GO:0018101) |
0.3 | 6.0 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.3 | 1.6 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.3 | 0.3 | GO:0050904 | diapedesis(GO:0050904) |
0.3 | 0.6 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.3 | 0.9 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.3 | 1.9 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.3 | 0.6 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.3 | 0.3 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.3 | 3.4 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.3 | 2.4 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.3 | 0.9 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.3 | 1.5 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.3 | 1.5 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.3 | 6.4 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.3 | 0.3 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.3 | 1.2 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.3 | 0.6 | GO:1901727 | regulation of histone deacetylase activity(GO:1901725) positive regulation of histone deacetylase activity(GO:1901727) |
0.3 | 1.8 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.3 | 1.2 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.3 | 2.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.3 | 2.7 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.3 | 0.3 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.3 | 0.3 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.3 | 1.5 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.3 | 2.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.3 | 2.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.3 | 0.3 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.3 | 0.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.3 | 5.9 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.3 | 1.2 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.3 | 0.6 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.3 | 0.6 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.3 | 0.9 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.3 | 3.5 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) |
0.3 | 4.0 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.3 | 0.3 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.3 | 3.4 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.3 | 0.6 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.3 | 5.4 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.3 | 1.7 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.3 | 0.3 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.3 | 2.3 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.3 | 0.8 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.3 | 1.7 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.3 | 1.7 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.3 | 1.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.3 | 0.6 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.3 | 1.7 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.3 | 0.6 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.3 | 2.8 | GO:0071514 | genetic imprinting(GO:0071514) |
0.3 | 1.1 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.3 | 0.3 | GO:0007494 | midgut development(GO:0007494) |
0.3 | 1.1 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.3 | 0.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.3 | 0.8 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.3 | 1.9 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.3 | 0.5 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.3 | 3.8 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.3 | 0.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.3 | 0.3 | GO:0009750 | response to fructose(GO:0009750) |
0.3 | 1.1 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.3 | 0.3 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.3 | 1.6 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.3 | 4.0 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.3 | 0.3 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.3 | 2.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.3 | 1.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.3 | 3.7 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.3 | 0.3 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.3 | 1.8 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.3 | 0.8 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.3 | 1.0 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.3 | 2.6 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.3 | 3.1 | GO:0021591 | ventricular system development(GO:0021591) |
0.3 | 1.8 | GO:0098534 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.3 | 3.6 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.3 | 0.8 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.3 | 0.8 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.3 | 1.8 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.3 | 1.5 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.3 | 0.5 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.3 | 0.5 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.3 | 0.3 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.3 | 0.3 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.3 | 1.0 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.3 | 0.8 | GO:0032914 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.3 | 2.3 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.3 | 1.5 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.3 | 3.3 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.3 | 1.5 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.3 | 0.3 | GO:0070316 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) |
0.3 | 0.3 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.2 | 0.2 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.2 | 2.5 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.2 | 6.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.2 | 0.5 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 1.7 | GO:0033866 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.2 | 1.7 | GO:0007379 | segment specification(GO:0007379) |
0.2 | 1.7 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.2 | 1.5 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.2 | 0.2 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.2 | 3.9 | GO:1901998 | toxin transport(GO:1901998) |
0.2 | 2.2 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.2 | 0.2 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) |
0.2 | 1.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 0.5 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 0.2 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.2 | 1.0 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.2 | 0.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 5.5 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.2 | 0.7 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.2 | 0.5 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.2 | 1.9 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.2 | 0.7 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.2 | 0.5 | GO:0015755 | fructose transport(GO:0015755) |
0.2 | 4.7 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.2 | 0.9 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.2 | 0.7 | GO:0006825 | copper ion transport(GO:0006825) |
0.2 | 6.3 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.2 | 0.2 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.2 | 0.9 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.2 | 0.5 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.2 | 0.5 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.2 | 2.7 | GO:0032967 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.2 | 0.2 | GO:0060157 | urinary bladder development(GO:0060157) |
0.2 | 1.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.2 | 0.2 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.2 | 0.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 5.1 | GO:0031497 | chromatin assembly(GO:0031497) |
0.2 | 2.7 | GO:0046677 | response to antibiotic(GO:0046677) |
0.2 | 0.4 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.2 | 1.1 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.2 | 0.4 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
0.2 | 0.9 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 0.7 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.2 | 1.5 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.2 | 0.6 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 0.6 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.2 | 0.9 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.2 | 0.4 | GO:0090329 | regulation of DNA-dependent DNA replication(GO:0090329) |
0.2 | 0.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 0.2 | GO:2001140 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.2 | 0.9 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.8 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.2 | 0.4 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.2 | 0.2 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.2 | 0.2 | GO:1902023 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.2 | 0.2 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.2 | 0.4 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.2 | 0.2 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.2 | 1.4 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 0.6 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.2 | 1.2 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.2 | 0.2 | GO:1902914 | regulation of protein polyubiquitination(GO:1902914) |
0.2 | 1.6 | GO:0048535 | lymph node development(GO:0048535) |
0.2 | 0.6 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.2 | 0.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.2 | 2.6 | GO:0000154 | rRNA modification(GO:0000154) |
0.2 | 0.8 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.2 | 1.0 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 0.8 | GO:0033572 | transferrin transport(GO:0033572) |
0.2 | 3.0 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.2 | 0.6 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.2 | 2.0 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.2 | 0.6 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.2 | 1.2 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.2 | 0.2 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.2 | 2.9 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.2 | 1.8 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.2 | 0.8 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.2 | 3.5 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.2 | 1.6 | GO:0006415 | translational termination(GO:0006415) |
0.2 | 0.8 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.2 | 0.4 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.2 | 6.6 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.2 | 2.7 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.2 | 0.6 | GO:0015817 | histidine transport(GO:0015817) |
0.2 | 0.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 4.9 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.2 | 0.8 | GO:0038202 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) |
0.2 | 0.6 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.2 | 1.5 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.2 | 0.6 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 1.5 | GO:0007141 | male meiosis I(GO:0007141) |
0.2 | 0.4 | GO:0051352 | negative regulation of ligase activity(GO:0051352) |
0.2 | 0.6 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.2 | 0.8 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.2 | 1.3 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.2 | 0.2 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.2 | 0.6 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.2 | 0.6 | GO:0032570 | response to progesterone(GO:0032570) |
0.2 | 2.6 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.2 | 0.4 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 2.9 | GO:0007051 | spindle organization(GO:0007051) |
0.2 | 4.0 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.2 | 1.3 | GO:0071548 | response to dexamethasone(GO:0071548) |
0.2 | 0.2 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.2 | 0.5 | GO:0061213 | positive regulation of mesonephros development(GO:0061213) |
0.2 | 0.5 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.2 | 0.4 | GO:1901722 | regulation of cell proliferation involved in kidney development(GO:1901722) |
0.2 | 0.2 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) cardiac muscle cell myoblast differentiation(GO:0060379) |
0.2 | 1.9 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.2 | 1.4 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.2 | 0.7 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 1.8 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.2 | 2.6 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.2 | 0.4 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.2 | 1.0 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.2 | 1.2 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.2 | 0.2 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.2 | 0.3 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.2 | 0.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.2 | 2.1 | GO:0017145 | stem cell division(GO:0017145) |
0.2 | 0.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.2 | 1.0 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.2 | 1.0 | GO:1904358 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.2 | 0.3 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.2 | 1.7 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.2 | 2.4 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.2 | 0.2 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.2 | 1.0 | GO:0015858 | nucleoside transport(GO:0015858) |
0.2 | 1.5 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.2 | 3.7 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.2 | 1.0 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.2 | 0.5 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.2 | 1.0 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.2 | 30.6 | GO:0008380 | RNA splicing(GO:0008380) |
0.2 | 0.2 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.2 | 1.0 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.2 | 1.3 | GO:0006342 | chromatin silencing(GO:0006342) |
0.2 | 0.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.2 | 1.0 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 1.3 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.2 | 0.5 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.2 | 0.3 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.2 | 0.3 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.2 | 0.3 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 0.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 3.7 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.2 | 0.3 | GO:0051031 | tRNA transport(GO:0051031) |
0.2 | 0.6 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.2 | 1.4 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.2 | 0.2 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.2 | 0.3 | GO:0070873 | regulation of glycogen metabolic process(GO:0070873) |
0.2 | 0.8 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.2 | 1.6 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.2 | 0.3 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.2 | 0.6 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.2 | 1.7 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.2 | 0.2 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.2 | 1.1 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.2 | 1.7 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.2 | 0.6 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.2 | 0.5 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.2 | 0.3 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.2 | 0.5 | GO:0044845 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.1 | 1.9 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 0.3 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 0.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 1.3 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.6 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 0.4 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 0.9 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 0.1 | GO:2000739 | regulation of mesenchymal stem cell differentiation(GO:2000739) |
0.1 | 1.0 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.1 | 0.1 | GO:1901163 | trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) |
0.1 | 0.4 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 9.9 | GO:0007059 | chromosome segregation(GO:0007059) |
0.1 | 0.1 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.1 | 0.4 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 0.3 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.4 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.4 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.5 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.1 | GO:1901797 | negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.1 | 0.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 0.8 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 2.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 1.4 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 0.3 | GO:0000436 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite activation of transcription(GO:0045991) |
0.1 | 0.4 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.5 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.1 | 0.3 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.1 | 0.4 | GO:0045821 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.1 | 0.3 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 8.2 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.1 | 0.3 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.1 | 0.4 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.1 | 0.4 | GO:0018904 | ether metabolic process(GO:0018904) |
0.1 | 0.1 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.1 | 0.1 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 0.1 | GO:0038066 | p38MAPK cascade(GO:0038066) |
0.1 | 1.4 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.1 | 3.2 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.1 | GO:1990774 | regulation of tumor necrosis factor secretion(GO:1904467) tumor necrosis factor secretion(GO:1990774) |
0.1 | 1.1 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.5 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.1 | 0.7 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 0.2 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 1.4 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 3.5 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.1 | 0.4 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.1 | 0.1 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.1 | 0.1 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.1 | 0.6 | GO:1902547 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.1 | 0.1 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.1 | 0.6 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.2 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.1 | 0.2 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.1 | 1.8 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.1 | GO:1901028 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901028) |
0.1 | 0.8 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.1 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.1 | 0.1 | GO:0002159 | desmosome assembly(GO:0002159) |
0.1 | 0.1 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.1 | 1.4 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.1 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
0.1 | 0.4 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.1 | 0.3 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.7 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 0.9 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 2.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.1 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.1 | 0.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 2.2 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 1.0 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.3 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 0.3 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.1 | 0.6 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.3 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.1 | 3.7 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.2 | GO:0030575 | nuclear body organization(GO:0030575) |
0.1 | 0.3 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.1 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
0.1 | 1.5 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.1 | 0.3 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.6 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.1 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.1 | 1.2 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.1 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.1 | 0.4 | GO:0015791 | polyol transport(GO:0015791) |
0.1 | 0.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 1.9 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.1 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.1 | 0.1 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.1 | 0.2 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.5 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 1.6 | GO:0050881 | multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
0.1 | 0.2 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.3 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 2.5 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.5 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.1 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.1 | 0.6 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.1 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.1 | 0.3 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 0.4 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.1 | 0.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.6 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.1 | 1.7 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 0.2 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.1 | 0.2 | GO:0097286 | iron ion import(GO:0097286) |
0.1 | 0.3 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.1 | 0.7 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.1 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.1 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.1 | 1.4 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.1 | 0.3 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.1 | 0.1 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.1 | 0.3 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.8 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 0.2 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 0.5 | GO:2000351 | regulation of endothelial cell apoptotic process(GO:2000351) |
0.1 | 0.4 | GO:0045639 | positive regulation of myeloid cell differentiation(GO:0045639) |
0.1 | 0.3 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
0.1 | 0.2 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.1 | 0.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 0.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 1.0 | GO:0060612 | adipose tissue development(GO:0060612) |
0.1 | 2.8 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.1 | 7.3 | GO:0016568 | chromatin modification(GO:0016568) |
0.1 | 0.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.1 | GO:0060100 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.1 | 0.5 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.1 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.1 | 0.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.2 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 0.1 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.1 | 0.1 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.1 | 0.1 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.1 | 1.8 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.1 | 0.3 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
0.1 | 0.2 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.1 | 0.1 | GO:0019755 | one-carbon compound transport(GO:0019755) |
0.1 | 0.1 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.1 | 0.1 | GO:1903337 | positive regulation of vacuolar transport(GO:1903337) |
0.1 | 0.9 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 0.3 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.1 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.1 | 0.4 | GO:0007098 | centrosome cycle(GO:0007098) |
0.1 | 0.4 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.1 | 0.1 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.1 | 0.3 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.1 | 0.3 | GO:0071824 | protein-DNA complex subunit organization(GO:0071824) |
0.1 | 0.2 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.3 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 1.2 | GO:0010634 | positive regulation of epithelial cell migration(GO:0010634) |
0.1 | 0.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.1 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 0.1 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 1.1 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.3 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.1 | 0.1 | GO:0031033 | myosin filament organization(GO:0031033) |
0.1 | 0.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 0.1 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.1 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) |
0.1 | 0.3 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.2 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 0.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.1 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.1 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.1 | 0.2 | GO:0003352 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
0.1 | 0.2 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 0.4 | GO:0071616 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.1 | 0.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 0.1 | GO:0009110 | vitamin biosynthetic process(GO:0009110) |
0.1 | 0.3 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 0.4 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.1 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 0.2 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.1 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.1 | 0.1 | GO:0045402 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
0.1 | 0.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.5 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.1 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.1 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.1 | 0.8 | GO:0006378 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.1 | 0.2 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.1 | 1.4 | GO:0051236 | establishment of RNA localization(GO:0051236) |
0.1 | 0.2 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.1 | 0.6 | GO:0071897 | DNA biosynthetic process(GO:0071897) |
0.1 | 0.1 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.1 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.1 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.2 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 0.1 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.1 | 0.1 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.0 | 0.1 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.0 | 0.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.0 | 0.0 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.0 | 0.0 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.0 | 0.0 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.0 | 0.0 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.0 | 0.0 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.0 | 0.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.0 | 0.2 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.0 | GO:0032329 | serine transport(GO:0032329) |
0.0 | 0.1 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.0 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.0 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.2 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.0 | 0.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.1 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.1 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.0 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.0 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.0 | 0.2 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.0 | 0.1 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.0 | 0.1 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.0 | 0.0 | GO:0060440 | trachea formation(GO:0060440) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.0 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.0 | 0.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.3 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.1 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.0 | 0.2 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.1 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.0 | 0.1 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.0 | 0.1 | GO:0040038 | polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
0.0 | 0.0 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.0 | 0.2 | GO:0042168 | heme metabolic process(GO:0042168) |
0.0 | 0.0 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.0 | 0.0 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.0 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.1 | GO:1900426 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) positive regulation of defense response to bacterium(GO:1900426) |
0.0 | 0.0 | GO:0009838 | abscission(GO:0009838) |
0.0 | 0.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.1 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.1 | GO:1903393 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of adherens junction organization(GO:1903393) |
0.0 | 0.1 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.0 | 0.1 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.1 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.0 | 0.1 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.0 | 0.1 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.0 | 0.0 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.0 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) prevention of polyspermy(GO:0060468) |
0.0 | 0.1 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 0.0 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
0.0 | 0.1 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.0 | 0.9 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.1 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) |
0.0 | 0.1 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.0 | 0.0 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.0 | 0.0 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.1 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.0 | 0.1 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.0 | 0.1 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.0 | 0.0 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.0 | 0.0 | GO:1903010 | regulation of bone development(GO:1903010) |
0.0 | 0.1 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.0 | 0.2 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.0 | GO:0070741 | response to interleukin-6(GO:0070741) |
0.0 | 0.1 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.0 | 0.1 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 | 0.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.1 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.1 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.0 | 0.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.1 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.0 | 0.4 | GO:0017144 | drug metabolic process(GO:0017144) |
0.0 | 0.0 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.0 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.0 | 0.0 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.0 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.0 | 0.1 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.0 | 0.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 0.0 | GO:1903299 | regulation of hexokinase activity(GO:1903299) |
0.0 | 0.1 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.0 | 0.0 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.0 | 0.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.0 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.0 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.0 | 0.1 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.0 | 0.0 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.0 | 0.0 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.0 | 0.0 | GO:0002215 | defense response to nematode(GO:0002215) |
0.0 | 0.0 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 0.0 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.0 | 0.0 | GO:0051462 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
0.0 | 0.0 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.0 | 0.0 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.0 | 0.1 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.0 | 0.0 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.0 | 0.1 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.0 | 0.0 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.0 | 0.1 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.1 | GO:0002507 | tolerance induction(GO:0002507) |
0.0 | 0.0 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.0 | 0.0 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.1 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.0 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.0 | 0.1 | GO:0043084 | penile erection(GO:0043084) |
0.0 | 0.0 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.0 | 0.0 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.0 | 0.0 | GO:0071374 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) cellular response to parathyroid hormone stimulus(GO:0071374) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.0 | 0.2 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.0 | 0.0 | GO:0044786 | nuclear DNA replication(GO:0033260) cell cycle DNA replication(GO:0044786) |
0.0 | 0.0 | GO:0060142 | regulation of syncytium formation by plasma membrane fusion(GO:0060142) |
0.0 | 0.0 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.0 | 0.0 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.0 | 0.0 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
0.0 | 0.0 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.0 | 0.0 | GO:0035581 | sequestering of extracellular ligand from receptor(GO:0035581) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.0 | 0.1 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.0 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.0 | 0.0 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.0 | 0.0 | GO:0033058 | directional locomotion(GO:0033058) |
0.0 | 0.0 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.0 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.0 | 0.1 | GO:0007127 | meiosis I(GO:0007127) |
0.0 | 0.0 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.0 | 0.1 | GO:0050892 | intestinal absorption(GO:0050892) |
0.0 | 0.0 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.0 | 0.0 | GO:0072676 | lymphocyte migration(GO:0072676) |
0.0 | 0.0 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.0 | 0.0 | GO:0006213 | pyrimidine nucleoside metabolic process(GO:0006213) |
0.0 | 0.0 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.0 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.0 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.0 | 0.0 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.1 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.0 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.2 | GO:0002687 | positive regulation of leukocyte migration(GO:0002687) |
0.0 | 0.0 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.0 | 0.0 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.0 | 0.0 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.0 | 0.0 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.0 | 0.1 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.3 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) |
0.0 | 0.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 13.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
4.3 | 25.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
2.8 | 8.4 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
2.7 | 10.8 | GO:0098536 | deuterosome(GO:0098536) |
2.7 | 37.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
2.6 | 7.9 | GO:0035061 | interchromatin granule(GO:0035061) |
2.6 | 7.8 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
2.6 | 18.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
2.5 | 10.1 | GO:0005642 | annulate lamellae(GO:0005642) |
2.5 | 12.6 | GO:0030870 | Mre11 complex(GO:0030870) |
2.4 | 19.4 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
2.1 | 12.9 | GO:0001940 | male pronucleus(GO:0001940) |
2.1 | 6.4 | GO:0043293 | apoptosome(GO:0043293) |
2.1 | 17.1 | GO:0001650 | fibrillar center(GO:0001650) |
2.1 | 2.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
2.1 | 6.3 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
2.1 | 12.4 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
2.0 | 8.2 | GO:0072487 | MSL complex(GO:0072487) |
2.0 | 9.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.9 | 3.9 | GO:0031523 | Myb complex(GO:0031523) |
1.9 | 7.6 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.8 | 7.4 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
1.8 | 9.2 | GO:0005638 | lamin filament(GO:0005638) |
1.8 | 7.3 | GO:0032389 | MutLalpha complex(GO:0032389) |
1.8 | 9.1 | GO:0061617 | MICOS complex(GO:0061617) |
1.8 | 7.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.7 | 6.9 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
1.7 | 5.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
1.7 | 6.7 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
1.6 | 4.9 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.6 | 4.7 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
1.6 | 6.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
1.5 | 9.2 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
1.5 | 6.0 | GO:0033269 | internode region of axon(GO:0033269) |
1.5 | 22.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
1.5 | 4.4 | GO:0097452 | GAIT complex(GO:0097452) |
1.5 | 8.7 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.4 | 7.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
1.4 | 4.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.4 | 2.8 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
1.3 | 6.7 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.3 | 3.9 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
1.3 | 9.1 | GO:0005652 | nuclear lamina(GO:0005652) |
1.3 | 5.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
1.3 | 5.1 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
1.3 | 5.1 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
1.3 | 5.0 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.2 | 3.7 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.2 | 35.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
1.2 | 3.6 | GO:0000811 | GINS complex(GO:0000811) |
1.2 | 10.7 | GO:0031010 | ISWI-type complex(GO:0031010) |
1.2 | 3.6 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
1.2 | 20.0 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
1.2 | 3.5 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
1.2 | 4.7 | GO:0070688 | MLL5-L complex(GO:0070688) |
1.1 | 4.6 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
1.1 | 9.2 | GO:0032797 | SMN complex(GO:0032797) |
1.1 | 3.4 | GO:0000814 | ESCRT II complex(GO:0000814) |
1.1 | 4.5 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
1.1 | 16.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.1 | 13.3 | GO:0071564 | npBAF complex(GO:0071564) |
1.1 | 7.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.1 | 3.3 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
1.1 | 24.0 | GO:0035861 | site of double-strand break(GO:0035861) |
1.1 | 7.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.1 | 3.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.1 | 3.2 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
1.0 | 9.4 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
1.0 | 3.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
1.0 | 3.1 | GO:0042827 | platelet dense granule(GO:0042827) |
1.0 | 4.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.0 | 11.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
1.0 | 3.1 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
1.0 | 7.1 | GO:0031931 | TORC1 complex(GO:0031931) |
1.0 | 11.0 | GO:0044232 | organelle membrane contact site(GO:0044232) |
1.0 | 6.0 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
1.0 | 11.9 | GO:0031616 | spindle pole centrosome(GO:0031616) |
1.0 | 4.0 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
1.0 | 3.0 | GO:0000805 | X chromosome(GO:0000805) |
1.0 | 7.9 | GO:0070652 | HAUS complex(GO:0070652) |
1.0 | 6.9 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
1.0 | 2.9 | GO:0000125 | PCAF complex(GO:0000125) |
1.0 | 3.9 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
1.0 | 7.8 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
1.0 | 2.9 | GO:0022624 | proteasome accessory complex(GO:0022624) |
1.0 | 2.9 | GO:0072687 | meiotic spindle(GO:0072687) |
1.0 | 12.5 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
1.0 | 11.4 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
1.0 | 5.7 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.9 | 9.5 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.9 | 6.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.9 | 1.9 | GO:0001939 | female pronucleus(GO:0001939) |
0.9 | 2.8 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.9 | 0.9 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.9 | 5.4 | GO:0070847 | core mediator complex(GO:0070847) |
0.9 | 7.2 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.9 | 9.8 | GO:0016580 | Sin3 complex(GO:0016580) |
0.9 | 18.6 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.9 | 8.7 | GO:0090544 | BAF-type complex(GO:0090544) |
0.9 | 14.8 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.9 | 7.8 | GO:0030914 | STAGA complex(GO:0030914) |
0.9 | 12.1 | GO:0097440 | apical dendrite(GO:0097440) |
0.9 | 2.6 | GO:0030689 | Noc complex(GO:0030689) |
0.9 | 3.4 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.9 | 1.7 | GO:1903349 | omegasome membrane(GO:1903349) |
0.9 | 0.9 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.9 | 1.7 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.8 | 5.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.8 | 6.7 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.8 | 0.8 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.8 | 44.3 | GO:0016605 | PML body(GO:0016605) |
0.8 | 10.6 | GO:0036038 | MKS complex(GO:0036038) |
0.8 | 2.4 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.8 | 16.9 | GO:0000791 | euchromatin(GO:0000791) |
0.8 | 10.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.8 | 16.7 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.8 | 4.8 | GO:0045120 | pronucleus(GO:0045120) |
0.8 | 2.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.8 | 2.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.8 | 8.6 | GO:0032039 | integrator complex(GO:0032039) |
0.8 | 5.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.8 | 3.1 | GO:0005687 | U4 snRNP(GO:0005687) |
0.8 | 4.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.8 | 17.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.8 | 6.0 | GO:0010369 | chromocenter(GO:0010369) |
0.8 | 3.8 | GO:0000235 | astral microtubule(GO:0000235) |
0.7 | 3.7 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.7 | 2.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.7 | 2.2 | GO:0035102 | PRC1 complex(GO:0035102) |
0.7 | 6.4 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.7 | 23.7 | GO:0045171 | intercellular bridge(GO:0045171) |
0.7 | 9.7 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.7 | 2.1 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.7 | 33.0 | GO:0016363 | nuclear matrix(GO:0016363) |
0.7 | 6.2 | GO:0034709 | methylosome(GO:0034709) |
0.7 | 14.4 | GO:0051233 | spindle midzone(GO:0051233) |
0.7 | 5.5 | GO:0005685 | U1 snRNP(GO:0005685) |
0.7 | 2.0 | GO:0097443 | sorting endosome(GO:0097443) |
0.7 | 39.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.7 | 5.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.6 | 0.6 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.6 | 16.7 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.6 | 1.3 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.6 | 8.9 | GO:0031528 | microvillus membrane(GO:0031528) |
0.6 | 1.9 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.6 | 3.8 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.6 | 6.9 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.6 | 5.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.6 | 1.3 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.6 | 7.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.6 | 1.8 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.6 | 3.0 | GO:0038201 | TOR complex(GO:0038201) |
0.6 | 12.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.6 | 6.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.6 | 5.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.6 | 9.1 | GO:0034399 | nuclear periphery(GO:0034399) |
0.6 | 0.6 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.6 | 2.8 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.6 | 6.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.6 | 1.1 | GO:1990357 | terminal web(GO:1990357) |
0.6 | 1.1 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.6 | 2.8 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.5 | 1.6 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.5 | 4.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.5 | 2.2 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.5 | 2.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.5 | 17.3 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.5 | 2.7 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.5 | 2.7 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.5 | 3.2 | GO:0031415 | NatA complex(GO:0031415) |
0.5 | 3.7 | GO:0044327 | dendritic spine head(GO:0044327) |
0.5 | 2.1 | GO:0035363 | histone locus body(GO:0035363) |
0.5 | 2.6 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.5 | 0.5 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.5 | 2.5 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.5 | 1.5 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.5 | 2.5 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.5 | 1.0 | GO:0070552 | BRISC complex(GO:0070552) |
0.5 | 2.0 | GO:0000938 | GARP complex(GO:0000938) |
0.5 | 5.3 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.5 | 1.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.5 | 96.4 | GO:0000785 | chromatin(GO:0000785) |
0.5 | 46.6 | GO:0016604 | nuclear body(GO:0016604) |
0.5 | 0.5 | GO:0042585 | germinal vesicle(GO:0042585) |
0.5 | 4.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.5 | 0.9 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.4 | 0.9 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.4 | 1.3 | GO:0030894 | replisome(GO:0030894) |
0.4 | 3.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.4 | 4.3 | GO:0000793 | condensed chromosome(GO:0000793) |
0.4 | 7.8 | GO:0043034 | costamere(GO:0043034) |
0.4 | 0.4 | GO:1990423 | RZZ complex(GO:1990423) |
0.4 | 1.7 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.4 | 1.7 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.4 | 6.7 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.4 | 2.1 | GO:1990391 | DNA repair complex(GO:1990391) |
0.4 | 4.9 | GO:0031430 | M band(GO:0031430) |
0.4 | 4.5 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.4 | 12.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.4 | 0.4 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.4 | 9.7 | GO:0097228 | sperm principal piece(GO:0097228) |
0.4 | 2.4 | GO:0000801 | central element(GO:0000801) |
0.4 | 0.8 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.4 | 0.4 | GO:0055087 | Ski complex(GO:0055087) |
0.4 | 2.0 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.4 | 24.8 | GO:0005814 | centriole(GO:0005814) |
0.4 | 0.4 | GO:0061574 | ASAP complex(GO:0061574) |
0.4 | 3.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.4 | 11.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.4 | 2.7 | GO:0000242 | pericentriolar material(GO:0000242) |
0.4 | 0.8 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.4 | 1.5 | GO:0071817 | MMXD complex(GO:0071817) |
0.4 | 1.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.4 | 36.6 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.4 | 5.6 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.4 | 2.2 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.4 | 1.8 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.4 | 25.3 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.4 | 1.1 | GO:0001652 | granular component(GO:0001652) |
0.4 | 2.1 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.3 | 6.5 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.3 | 2.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 0.7 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.3 | 0.7 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.3 | 1.0 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.3 | 2.7 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.3 | 0.7 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.3 | 0.3 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.3 | 1.9 | GO:0071986 | Ragulator complex(GO:0071986) |
0.3 | 1.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.3 | 0.6 | GO:0005915 | zonula adherens(GO:0005915) |
0.3 | 1.6 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.3 | 1.3 | GO:1990130 | Iml1 complex(GO:1990130) |
0.3 | 2.8 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.3 | 1.6 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.3 | 0.6 | GO:0071942 | XPC complex(GO:0071942) |
0.3 | 19.0 | GO:0005694 | chromosome(GO:0005694) |
0.3 | 1.2 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.3 | 1.5 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.3 | 5.9 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.3 | 1.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.3 | 18.8 | GO:0005902 | microvillus(GO:0005902) |
0.3 | 1.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.3 | 0.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.3 | 1.5 | GO:0045179 | apical cortex(GO:0045179) |
0.3 | 1.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.3 | 0.9 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.3 | 3.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.3 | 0.9 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.3 | 3.5 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.3 | 9.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.3 | 0.3 | GO:0098803 | respiratory chain complex(GO:0098803) |
0.3 | 2.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.3 | 1.9 | GO:0070938 | contractile ring(GO:0070938) |
0.3 | 0.3 | GO:0016939 | kinesin II complex(GO:0016939) |
0.3 | 288.4 | GO:0005654 | nucleoplasm(GO:0005654) |
0.3 | 1.6 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.3 | 1.9 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 0.5 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.3 | 0.8 | GO:0070820 | tertiary granule(GO:0070820) |
0.3 | 0.8 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.3 | 0.8 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.3 | 1.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.3 | 0.5 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.3 | 0.8 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.3 | 0.3 | GO:1990745 | EARP complex(GO:1990745) |
0.3 | 2.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.3 | 0.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 1.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 3.5 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 2.2 | GO:0030663 | COPI vesicle coat(GO:0030126) COPI-coated vesicle membrane(GO:0030663) |
0.2 | 0.7 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 3.3 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 0.5 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 4.0 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.2 | 1.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 7.2 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.2 | 2.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 1.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 3.0 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 6.5 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 0.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 0.6 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 2.2 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 0.8 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 6.4 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.2 | 0.8 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 9.5 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.2 | 1.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 1.0 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 0.4 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.2 | 2.7 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.2 | 0.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 2.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 0.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.2 | 1.9 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.2 | 1.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 10.0 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.2 | 3.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 0.5 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 1.6 | GO:0005844 | polysome(GO:0005844) |
0.2 | 1.2 | GO:0031672 | A band(GO:0031672) |
0.2 | 0.5 | GO:0002177 | manchette(GO:0002177) |
0.2 | 2.6 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 0.3 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 1.2 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 0.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 0.5 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 21.1 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 11.8 | GO:0031514 | motile cilium(GO:0031514) |
0.2 | 0.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 0.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 1.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 0.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.2 | 0.9 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 1.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.2 | 5.4 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 0.5 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 1.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 0.6 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.2 | 7.0 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 0.5 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.4 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 2.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.4 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 39.8 | GO:0031981 | nuclear lumen(GO:0031981) |
0.1 | 0.5 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.9 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 1.1 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 2.1 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 0.3 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 1.0 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 5.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 1.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 1.2 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.7 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.1 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
0.1 | 1.4 | GO:0070069 | cytochrome complex(GO:0070069) |
0.1 | 0.8 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 0.4 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.8 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 3.1 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.6 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 12.2 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 0.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 4.2 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 8.2 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.3 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.3 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 0.7 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 1.5 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.1 | 1.6 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 205.7 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 2.5 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 0.6 | GO:0002102 | podosome(GO:0002102) |
0.1 | 1.2 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 30.7 | GO:0044429 | mitochondrial part(GO:0044429) |
0.1 | 0.1 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 3.7 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.1 | 0.3 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.1 | 3.2 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 0.3 | GO:0044217 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 0.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 0.2 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 3.9 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.7 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 4.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.4 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 0.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.8 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.5 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.0 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 1.0 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.3 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 2.3 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.1 | GO:0044292 | dendrite terminus(GO:0044292) |
0.0 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.0 | 0.2 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.1 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.0 | 0.6 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.1 | GO:1904949 | ATPase complex(GO:1904949) |
0.0 | 0.2 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.1 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.0 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.1 | GO:0044194 | cytolytic granule(GO:0044194) |
0.0 | 0.0 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 1.1 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.0 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 0.1 | GO:0030135 | coated vesicle(GO:0030135) |
0.0 | 0.0 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.0 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.0 | 0.0 | GO:0043205 | fibril(GO:0043205) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.3 | 19.0 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
4.4 | 13.1 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
3.1 | 9.3 | GO:0005119 | smoothened binding(GO:0005119) |
2.9 | 11.6 | GO:0070878 | primary miRNA binding(GO:0070878) |
2.8 | 11.4 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
2.8 | 8.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
2.6 | 7.9 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
2.6 | 15.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
2.6 | 15.3 | GO:0004064 | arylesterase activity(GO:0004064) |
2.5 | 12.6 | GO:0000405 | bubble DNA binding(GO:0000405) |
2.5 | 9.8 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
2.4 | 19.1 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
2.4 | 7.1 | GO:1990188 | euchromatin binding(GO:1990188) |
2.4 | 4.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
2.3 | 9.4 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
2.3 | 9.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
2.3 | 2.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
2.3 | 6.9 | GO:0070644 | vitamin D response element binding(GO:0070644) |
2.2 | 2.2 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
2.2 | 4.4 | GO:1990715 | mRNA CDS binding(GO:1990715) |
2.2 | 6.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
2.1 | 8.3 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
2.1 | 10.4 | GO:0032135 | DNA insertion or deletion binding(GO:0032135) |
2.1 | 26.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
1.9 | 3.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
1.9 | 7.6 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
1.9 | 5.6 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
1.8 | 7.4 | GO:0033142 | progesterone receptor binding(GO:0033142) |
1.8 | 9.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.8 | 1.8 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
1.8 | 1.8 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
1.8 | 1.8 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
1.7 | 5.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
1.7 | 5.2 | GO:0035877 | death effector domain binding(GO:0035877) |
1.7 | 8.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.7 | 1.7 | GO:0070410 | co-SMAD binding(GO:0070410) |
1.7 | 3.4 | GO:0019237 | centromeric DNA binding(GO:0019237) |
1.7 | 5.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
1.6 | 9.8 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
1.6 | 1.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
1.6 | 6.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.6 | 6.3 | GO:0030983 | mismatched DNA binding(GO:0030983) |
1.6 | 6.2 | GO:0002060 | purine nucleobase binding(GO:0002060) |
1.5 | 7.6 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
1.5 | 6.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
1.5 | 4.6 | GO:0019961 | interferon binding(GO:0019961) |
1.5 | 10.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.5 | 4.4 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
1.5 | 5.8 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
1.4 | 8.7 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.4 | 10.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
1.4 | 4.3 | GO:0001031 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
1.4 | 12.9 | GO:0031386 | protein tag(GO:0031386) |
1.4 | 5.6 | GO:0015232 | heme transporter activity(GO:0015232) |
1.4 | 2.8 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
1.4 | 26.6 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
1.4 | 18.0 | GO:0008432 | JUN kinase binding(GO:0008432) |
1.4 | 13.7 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
1.4 | 8.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
1.3 | 6.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.3 | 10.4 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
1.3 | 5.1 | GO:0043515 | kinetochore binding(GO:0043515) |
1.3 | 5.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
1.2 | 3.7 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
1.2 | 22.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
1.2 | 3.6 | GO:0019002 | GMP binding(GO:0019002) |
1.2 | 7.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
1.2 | 3.6 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
1.2 | 3.6 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
1.2 | 6.0 | GO:0070061 | fructose binding(GO:0070061) |
1.2 | 5.9 | GO:1990239 | steroid hormone binding(GO:1990239) |
1.2 | 1.2 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
1.2 | 4.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.2 | 3.5 | GO:0004359 | glutaminase activity(GO:0004359) |
1.2 | 8.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
1.2 | 3.5 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
1.1 | 12.6 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
1.1 | 3.4 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.1 | 4.5 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
1.1 | 3.4 | GO:0030957 | Tat protein binding(GO:0030957) |
1.1 | 3.3 | GO:0050692 | DBD domain binding(GO:0050692) |
1.1 | 3.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
1.1 | 1.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.0 | 8.4 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
1.0 | 3.1 | GO:0030519 | snoRNP binding(GO:0030519) |
1.0 | 3.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
1.0 | 14.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
1.0 | 2.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
1.0 | 4.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
1.0 | 3.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
1.0 | 9.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
1.0 | 8.1 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
1.0 | 2.0 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.0 | 3.0 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
1.0 | 21.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
1.0 | 9.0 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
1.0 | 11.0 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
1.0 | 3.0 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.0 | 7.9 | GO:0001222 | transcription corepressor binding(GO:0001222) |
1.0 | 4.9 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.0 | 27.3 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
1.0 | 3.8 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
1.0 | 2.9 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.9 | 19.9 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.9 | 3.8 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) G-rich strand telomeric DNA binding(GO:0098505) |
0.9 | 3.8 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.9 | 3.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.9 | 3.8 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.9 | 32.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.9 | 2.8 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.9 | 3.7 | GO:0009374 | biotin binding(GO:0009374) |
0.9 | 2.7 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.9 | 5.4 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.9 | 3.6 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.9 | 7.2 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.9 | 9.9 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.9 | 12.5 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.9 | 18.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.9 | 3.6 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.9 | 2.7 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.9 | 25.6 | GO:0070888 | E-box binding(GO:0070888) |
0.9 | 2.6 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.9 | 5.3 | GO:0034046 | poly(G) binding(GO:0034046) |
0.9 | 3.5 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.9 | 0.9 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.9 | 7.8 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.9 | 2.6 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.9 | 4.3 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.9 | 0.9 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.9 | 8.5 | GO:0048156 | tau protein binding(GO:0048156) |
0.8 | 6.7 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.8 | 2.5 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.8 | 13.4 | GO:0005112 | Notch binding(GO:0005112) |
0.8 | 2.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.8 | 6.7 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.8 | 9.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.8 | 0.8 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.8 | 19.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.8 | 7.2 | GO:0018446 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.8 | 3.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.8 | 2.4 | GO:0097016 | L27 domain binding(GO:0097016) |
0.8 | 3.9 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.8 | 0.8 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.8 | 2.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.8 | 3.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.8 | 2.3 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.8 | 3.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.8 | 3.8 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.7 | 12.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.7 | 4.5 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.7 | 7.4 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.7 | 3.7 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.7 | 3.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.7 | 3.7 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.7 | 3.7 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.7 | 2.2 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.7 | 5.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.7 | 1.5 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.7 | 5.0 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.7 | 4.3 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.7 | 5.0 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.7 | 10.0 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.7 | 4.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.7 | 8.4 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.7 | 4.2 | GO:1990405 | protein antigen binding(GO:1990405) |
0.7 | 20.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.7 | 4.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.7 | 6.9 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.7 | 3.4 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.7 | 1.4 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.7 | 2.7 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.7 | 2.7 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.7 | 2.0 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.7 | 6.0 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.7 | 2.7 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.7 | 3.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.7 | 9.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.7 | 6.6 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.7 | 17.7 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.7 | 2.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.7 | 1.3 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.7 | 2.0 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.7 | 12.4 | GO:0030506 | ankyrin binding(GO:0030506) |
0.6 | 0.6 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.6 | 3.9 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.6 | 1.9 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.6 | 12.2 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.6 | 2.6 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.6 | 3.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.6 | 1.9 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.6 | 1.9 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.6 | 4.4 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.6 | 1.9 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.6 | 19.8 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.6 | 12.3 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.6 | 2.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.6 | 1.8 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.6 | 2.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.6 | 4.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.6 | 2.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.6 | 4.9 | GO:0042300 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.6 | 4.8 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.6 | 4.8 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.6 | 23.5 | GO:0035064 | methylated histone binding(GO:0035064) |
0.6 | 11.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.6 | 5.3 | GO:0035173 | histone kinase activity(GO:0035173) |
0.6 | 3.5 | GO:0034452 | dynactin binding(GO:0034452) |
0.6 | 3.0 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.6 | 2.9 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.6 | 5.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.6 | 0.6 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.6 | 18.1 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.6 | 4.1 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.6 | 1.7 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.6 | 18.3 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.6 | 5.1 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.6 | 4.5 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.6 | 1.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.6 | 11.8 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.6 | 8.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.6 | 1.7 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.6 | 3.9 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.6 | 1.1 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.6 | 2.2 | GO:0034549 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.6 | 1.7 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.6 | 0.6 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.6 | 1.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.5 | 4.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.5 | 9.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.5 | 3.8 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.5 | 1.6 | GO:0000182 | rDNA binding(GO:0000182) |
0.5 | 8.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.5 | 1.6 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.5 | 2.7 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.5 | 5.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.5 | 1.6 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.5 | 2.7 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.5 | 1.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.5 | 1.6 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.5 | 0.5 | GO:0043559 | insulin binding(GO:0043559) |
0.5 | 1.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.5 | 10.8 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.5 | 5.1 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.5 | 1.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.5 | 3.0 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.5 | 7.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.5 | 2.0 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.5 | 1.0 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.5 | 2.0 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.5 | 1.0 | GO:0034618 | arginine binding(GO:0034618) |
0.5 | 1.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.5 | 11.4 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.5 | 1.0 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.5 | 1.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.5 | 3.5 | GO:0036122 | BMP binding(GO:0036122) |
0.5 | 2.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.5 | 2.0 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.5 | 2.9 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.5 | 1.5 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.5 | 5.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.5 | 0.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.5 | 1.4 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.5 | 3.8 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.5 | 1.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.5 | 1.9 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.5 | 1.4 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.5 | 0.5 | GO:0036033 | mediator complex binding(GO:0036033) |
0.5 | 7.0 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.5 | 1.4 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.5 | 0.9 | GO:0015928 | fucosidase activity(GO:0015928) |
0.5 | 4.6 | GO:0032183 | SUMO binding(GO:0032183) |
0.5 | 0.9 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.5 | 0.9 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.5 | 1.8 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.5 | 1.4 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.5 | 5.9 | GO:0001618 | virus receptor activity(GO:0001618) |
0.4 | 1.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.4 | 5.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.4 | 1.8 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.4 | 0.9 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.4 | 2.6 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.4 | 0.9 | GO:0030911 | TPR domain binding(GO:0030911) |
0.4 | 13.0 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.4 | 3.0 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.4 | 4.7 | GO:0044548 | S100 protein binding(GO:0044548) |
0.4 | 5.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.4 | 2.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.4 | 0.4 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.4 | 2.9 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.4 | 2.9 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.4 | 4.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.4 | 7.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.4 | 2.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.4 | 0.4 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.4 | 1.6 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.4 | 16.1 | GO:0035326 | enhancer binding(GO:0035326) |
0.4 | 1.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.4 | 3.6 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.4 | 9.9 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.4 | 1.9 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.4 | 1.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.4 | 2.7 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.4 | 1.2 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.4 | 11.2 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.4 | 5.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.4 | 1.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.4 | 1.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.4 | 1.9 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.4 | 1.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.4 | 1.5 | GO:0031491 | nucleosome binding(GO:0031491) |
0.4 | 1.9 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.4 | 2.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.4 | 13.3 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.4 | 7.7 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.4 | 1.8 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.4 | 2.6 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.4 | 1.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.4 | 1.1 | GO:0031432 | titin binding(GO:0031432) |
0.4 | 2.5 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.4 | 17.9 | GO:0042393 | histone binding(GO:0042393) |
0.4 | 1.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.4 | 0.4 | GO:0035198 | miRNA binding(GO:0035198) |
0.4 | 10.0 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.4 | 46.7 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.4 | 1.8 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.4 | 2.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.4 | 0.4 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.4 | 2.8 | GO:0005123 | death receptor binding(GO:0005123) |
0.3 | 12.2 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.3 | 1.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.3 | 3.5 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.3 | 1.7 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.3 | 7.2 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.3 | 1.7 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.3 | 2.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.3 | 1.7 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.3 | 18.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.3 | 0.7 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.3 | 5.4 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.3 | 1.0 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.3 | 2.0 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.3 | 2.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.3 | 8.7 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.3 | 1.0 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.3 | 14.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.3 | 0.7 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.3 | 1.0 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 2.9 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.3 | 3.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.3 | 1.3 | GO:0043566 | structure-specific DNA binding(GO:0043566) |
0.3 | 6.7 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.3 | 0.6 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.3 | 1.3 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.3 | 1.3 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.3 | 2.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 1.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.3 | 2.8 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.3 | 0.9 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.3 | 0.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.3 | 5.3 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.3 | 0.6 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.3 | 4.9 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 0.3 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.3 | 0.6 | GO:0002054 | nucleobase binding(GO:0002054) |
0.3 | 13.5 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.3 | 2.4 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 0.3 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.3 | 0.6 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.3 | 0.9 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.3 | 0.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.3 | 0.9 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.3 | 0.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.3 | 0.9 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.3 | 3.5 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.3 | 0.3 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.3 | 0.3 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.3 | 0.6 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.3 | 0.3 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.3 | 1.4 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.3 | 0.9 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.3 | 1.4 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.3 | 14.9 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.3 | 0.8 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.3 | 0.3 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.3 | 8.1 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.3 | 0.3 | GO:0004096 | catalase activity(GO:0004096) |
0.3 | 2.5 | GO:0030515 | snoRNA binding(GO:0030515) |
0.3 | 3.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.3 | 3.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.3 | 6.6 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.3 | 8.7 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.3 | 3.3 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.3 | 0.8 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.3 | 9.7 | GO:0000049 | tRNA binding(GO:0000049) |
0.3 | 0.5 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.3 | 2.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 18.4 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.3 | 25.2 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.3 | 1.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 1.0 | GO:0042731 | PH domain binding(GO:0042731) |
0.3 | 0.8 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.3 | 4.9 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.3 | 4.5 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.3 | 1.3 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.3 | 6.8 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.3 | 2.5 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.3 | 0.5 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.3 | 1.5 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.2 | 2.0 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.2 | 4.7 | GO:0001848 | complement binding(GO:0001848) |
0.2 | 1.2 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 2.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 0.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 2.0 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 1.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.7 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 4.8 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.2 | 2.9 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.2 | 23.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 4.7 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 0.7 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.2 | 0.7 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 2.8 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.2 | 2.5 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.2 | 2.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 0.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 2.1 | GO:0019841 | retinol binding(GO:0019841) |
0.2 | 0.5 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.2 | 1.8 | GO:0043864 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.2 | 0.7 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 1.4 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 1.8 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.2 | 1.1 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.2 | 0.9 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.2 | 4.9 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.2 | 0.7 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.2 | 2.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 0.2 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.2 | 2.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.2 | 5.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 0.9 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 12.1 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.2 | 8.0 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.2 | 0.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 0.6 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.2 | 0.9 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.2 | 1.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 0.9 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.2 | 38.0 | GO:0003682 | chromatin binding(GO:0003682) |
0.2 | 1.9 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 8.7 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.2 | 2.3 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.2 | 0.4 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.2 | 0.2 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.2 | 1.9 | GO:0004527 | exonuclease activity(GO:0004527) |
0.2 | 2.3 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.2 | 0.2 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.2 | 3.3 | GO:0019239 | deaminase activity(GO:0019239) |
0.2 | 1.4 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 1.8 | GO:0034793 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.2 | 0.6 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.2 | 6.9 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.2 | 0.8 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 0.4 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.2 | 2.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 0.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 1.0 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.2 | 0.8 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 0.6 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.2 | 5.9 | GO:0043621 | protein self-association(GO:0043621) |
0.2 | 3.8 | GO:0016875 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.2 | 0.9 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 0.4 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.2 | 0.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 1.3 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.2 | 1.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 6.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 0.2 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.2 | 1.1 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.2 | 2.6 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 1.3 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.2 | 0.7 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.2 | 111.4 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.2 | 1.6 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 2.9 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.2 | 1.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 1.9 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.2 | 0.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 0.9 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 0.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 1.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.2 | 41.3 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.2 | 1.8 | GO:0044466 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.2 | 0.5 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.2 | 0.5 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 1.0 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 1.0 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 0.5 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.2 | 0.2 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.2 | 0.8 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 0.9 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 0.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 2.3 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.2 | 0.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 0.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 0.5 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 1.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.2 | 0.3 | GO:0038100 | nodal binding(GO:0038100) |
0.2 | 0.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 9.2 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.1 | 0.7 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 0.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.6 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 3.6 | GO:0072341 | modified amino acid binding(GO:0072341) |
0.1 | 0.3 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 13.0 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 2.8 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 1.6 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.1 | 1.0 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.7 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 1.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.4 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 11.2 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 1.5 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 1.2 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.8 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.3 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.1 | 1.4 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.1 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 0.8 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.5 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 6.3 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 4.8 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.1 | 3.3 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.5 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.1 | 0.1 | GO:0070538 | oleic acid binding(GO:0070538) |
0.1 | 3.9 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 1.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.5 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 1.6 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 0.6 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 1.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.6 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 0.2 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.1 | 20.8 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 1.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 1.0 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 2.9 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 0.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.3 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
0.1 | 0.5 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.4 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 0.4 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 0.5 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.3 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.3 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.9 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 0.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.2 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 1.0 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.9 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.1 | 0.4 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 0.2 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.1 | 0.2 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 0.3 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 1.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 1.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 1.2 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 0.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 3.9 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 2.4 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.4 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 8.7 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.8 | GO:0008186 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 0.3 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 4.7 | GO:0004518 | nuclease activity(GO:0004518) |
0.1 | 0.2 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 0.3 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 0.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.1 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.1 | 0.7 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.1 | 0.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.2 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.1 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 1.3 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 0.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 0.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.2 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 0.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.2 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 0.2 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.1 | 0.2 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.1 | 4.8 | GO:0008134 | transcription factor binding(GO:0008134) |
0.1 | 0.2 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.7 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.1 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 0.3 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.1 | GO:0015926 | glucosidase activity(GO:0015926) |
0.1 | 0.1 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.1 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.6 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.4 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.2 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.0 | 0.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.1 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 1.2 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.0 | 0.1 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 0.2 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 1.0 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.2 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.2 | GO:0015265 | urea channel activity(GO:0015265) |
0.0 | 0.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.0 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.0 | 0.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.2 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.0 | 0.9 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.0 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.1 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
0.0 | 0.6 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.3 | GO:0032451 | demethylase activity(GO:0032451) |
0.0 | 0.1 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.0 | 0.8 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.0 | 0.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.1 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 1.3 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.0 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.0 | 0.1 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 0.0 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.0 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.0 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.1 | GO:0034791 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) phenanthrene 9,10-monooxygenase activity(GO:0018636) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.0 | 0.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.9 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 1.7 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 17.0 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 0.0 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.1 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.1 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.0 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.0 | GO:0018568 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.0 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.0 | 0.0 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.0 | GO:0015927 | trehalase activity(GO:0015927) |
0.0 | 0.0 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.0 | 0.0 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.0 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.0 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.0 | 0.3 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 18.7 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
1.6 | 25.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.5 | 3.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
1.4 | 2.9 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
1.4 | 23.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
1.3 | 16.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.1 | 21.1 | PID ARF 3PATHWAY | Arf1 pathway |
1.1 | 81.1 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
1.1 | 48.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.1 | 53.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
1.0 | 10.1 | PID MYC PATHWAY | C-MYC pathway |
1.0 | 11.8 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
1.0 | 51.4 | PID E2F PATHWAY | E2F transcription factor network |
0.9 | 26.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.9 | 3.7 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.9 | 13.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.9 | 28.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.9 | 14.7 | PID BARD1 PATHWAY | BARD1 signaling events |
0.8 | 9.9 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.8 | 10.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.8 | 2.4 | ST STAT3 PATHWAY | STAT3 Pathway |
0.8 | 6.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.8 | 6.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.8 | 7.5 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.7 | 7.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.7 | 17.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.7 | 13.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.7 | 27.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.7 | 5.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.7 | 3.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.7 | 2.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.7 | 17.5 | PID RHOA PATHWAY | RhoA signaling pathway |
0.7 | 14.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.7 | 18.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.7 | 22.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.6 | 26.6 | PID P73PATHWAY | p73 transcription factor network |
0.6 | 28.2 | PID NOTCH PATHWAY | Notch signaling pathway |
0.6 | 8.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.6 | 10.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.6 | 6.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.6 | 5.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.6 | 3.6 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.5 | 14.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.5 | 6.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.5 | 5.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.5 | 6.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.5 | 14.0 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.5 | 9.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.5 | 4.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.5 | 11.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.5 | 16.6 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.5 | 8.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.5 | 10.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.5 | 7.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.5 | 1.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.5 | 4.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.5 | 11.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.4 | 5.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.4 | 7.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.4 | 0.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.4 | 2.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.4 | 6.2 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.4 | 0.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.4 | 3.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.4 | 1.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.4 | 11.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.4 | 2.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.4 | 2.6 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.4 | 6.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.4 | 0.4 | PID EPO PATHWAY | EPO signaling pathway |
0.4 | 4.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.4 | 3.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 3.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.3 | 3.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.3 | 0.7 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.3 | 3.7 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.3 | 3.0 | PID INSULIN PATHWAY | Insulin Pathway |
0.3 | 6.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.3 | 1.7 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.3 | 2.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.3 | 0.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.3 | 2.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.3 | 1.6 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.3 | 2.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 4.7 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 2.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 2.7 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.2 | 3.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 1.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 0.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 2.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 2.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 0.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 3.9 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 1.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 1.5 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 1.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.9 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 2.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 1.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 2.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.9 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 2.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 0.6 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 1.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.4 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 0.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 0.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.3 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 1.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.0 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.2 | 30.8 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
2.5 | 2.5 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
2.2 | 2.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
2.0 | 22.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
1.9 | 1.9 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
1.8 | 42.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
1.6 | 9.7 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
1.6 | 23.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
1.6 | 17.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
1.5 | 40.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
1.5 | 24.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
1.3 | 3.9 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
1.3 | 11.8 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
1.3 | 12.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
1.2 | 3.7 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
1.2 | 1.2 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
1.2 | 27.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
1.1 | 18.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
1.1 | 8.7 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
1.1 | 2.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
1.0 | 21.8 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
1.0 | 2.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
1.0 | 13.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.0 | 27.5 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
1.0 | 4.9 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.9 | 14.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.9 | 12.5 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.9 | 7.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.9 | 8.7 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.9 | 44.8 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.9 | 11.1 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.9 | 3.4 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.8 | 14.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.8 | 19.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.8 | 20.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.8 | 10.7 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.8 | 2.4 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.8 | 41.4 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.8 | 9.6 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.8 | 1.6 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.8 | 4.8 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.8 | 11.9 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.8 | 3.9 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.8 | 3.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.8 | 7.7 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.8 | 16.7 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.8 | 43.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.7 | 6.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.7 | 17.6 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.7 | 14.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.7 | 4.9 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.7 | 10.5 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.7 | 0.7 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.7 | 4.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.7 | 3.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.7 | 2.7 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.7 | 3.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.7 | 7.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.6 | 8.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.6 | 0.6 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.6 | 7.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.6 | 6.2 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.6 | 6.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.6 | 10.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.6 | 4.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.6 | 6.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.6 | 37.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.6 | 15.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.6 | 0.6 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.6 | 11.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.6 | 5.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.6 | 4.6 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.6 | 5.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.6 | 4.4 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.5 | 10.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.5 | 3.2 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.5 | 3.1 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.5 | 13.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.5 | 1.5 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.5 | 11.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.5 | 5.4 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.5 | 1.9 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.5 | 3.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.5 | 4.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.5 | 1.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.5 | 15.8 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.5 | 0.9 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.4 | 4.5 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.4 | 12.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.4 | 6.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.4 | 1.7 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.4 | 2.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.4 | 5.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.4 | 7.5 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.4 | 3.3 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.4 | 5.9 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.4 | 0.8 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.4 | 4.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.4 | 1.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.4 | 4.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.4 | 5.8 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.4 | 6.5 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.4 | 6.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.4 | 8.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.4 | 6.0 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.4 | 8.7 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.4 | 3.9 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.4 | 2.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.4 | 4.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.4 | 4.7 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.4 | 3.6 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.4 | 8.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.4 | 6.0 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.4 | 3.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 12.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.3 | 2.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.3 | 2.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.3 | 1.9 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
0.3 | 0.6 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.3 | 8.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.3 | 1.6 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.3 | 20.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.3 | 2.8 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.3 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.3 | 2.5 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.3 | 3.4 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.3 | 13.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.3 | 5.0 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.3 | 3.1 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 1.1 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.3 | 1.6 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.3 | 2.4 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.3 | 0.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.3 | 13.2 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.3 | 1.9 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.3 | 0.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.3 | 4.8 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.3 | 5.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 0.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.3 | 3.4 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.3 | 4.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 0.5 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 1.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 2.0 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 26.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 4.2 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 5.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 2.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 1.6 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.2 | 2.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 2.5 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.2 | 4.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 3.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 7.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 1.7 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.2 | 2.1 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.2 | 3.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 1.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 12.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.2 | 2.0 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 4.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 2.1 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.2 | 4.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 0.5 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.2 | 14.7 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.2 | 2.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.2 | 2.4 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.2 | 1.4 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.2 | 1.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 1.4 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 2.3 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.1 | 0.4 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 0.8 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 0.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 1.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.8 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 0.2 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 1.5 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 0.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 0.8 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 0.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 0.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.6 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.5 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 1.1 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.7 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 1.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.8 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 0.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 0.6 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.3 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.0 | 0.7 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 0.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 0.5 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.0 | 0.4 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.2 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.0 | 0.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.0 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |